To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SAR1AandTYSND1andAIFM2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
790 representative clones for gene SAR1AandTYSND1andAIFM2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_173555.2   SAR1AandTYSND1andAIFM2.a 1 to 3801 2 to 3802 exact RefSeq,   3802/3802
(100 %)
0 diff
(100 %id)
AL528616 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized SAR1AandTYSND1andAIFM2.a 57 to 1070 1 to 1003   tiling clone,   1003/1067
(94 %)
18 diff
(98.4 %id)
BX396180 Placenta Cot 25-normalized SAR1AandTYSND1andAIFM2.a 57 to 1053 1 to 983       983/987
(99 %)
28 diff
(97.2 %id)
BC042629 Brain, adult medulla SAR1AandTYSND1andAIFM2.a 60 to 2565 1 to 2507 T65A A206G V207G S208V P209A ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2507/2507
(100 %)
3 diff
(99.9 %id)
BC111501 Brain, hippocampus SAR1AandTYSND1andAIFM2.a 61 to 2565 1 to 2505 T65A tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2505/2505
(100 %)
2 diff
(100.0 %id)
BC088729 Uterus, leiomyosarcoma SAR1AandTYSND1andAIFM2.a 93 to 2570 1 to 2478 T65A AAA   2478/7121
(34 %)
4 diff
(100.0 %id)
BC016840 Lung, carcinoma, large cellundifferentiated. SAR1AandTYSND1andAIFM2.a 546 to 2565 1 to 2020   available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2020/2020
(100 %)
1 diff
(100.0 %id)
BG682740 brain, neuroblastoma, cell line SAR1AandTYSND1andAIFM2.a 791 to 1511 1 to 718   tiling clone,   718/718
(100 %)
8 diff
(98.9 %id)
BM172052 brain, neuroblastoma, cell line SAR1AandTYSND1andAIFM2.a 792 to 1415 10 to 630       621/630
(98 %)
6 diff
(99.1 %id)
BX348505   SAR1AandTYSND1andAIFM2.a 926 to 1637 1 to 708       708/963
(73 %)
26 diff
(97.4 %id)
AA160412 Pancreas SAR1AandTYSND1andAIFM2.a 1240 to 1634 1 to 394       394/394
(100 %)
16 diff
(96.0 %id)
BE903673 choriocarcinoma, placenta SAR1AandTYSND1andAIFM2.a 1254 to 1955 9 to 710       702/710
(98 %)
11 diff
(98.5 %id)
BI832395 brain, medulla SAR1AandTYSND1andAIFM2.a 1319 to 2003 54 to 743       692/752
(92 %)
35 diff
(95.4 %id)
TI_57171234   SAR1AandTYSND1andAIFM2.a 1319 to 2003 54 to 743       692/752
(92 %)
35 diff
(95.4 %id)
BG330924 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.a 1325 to 2126 1 to 802       802/936
(85 %)
12 diff
(98.8 %id)
CN344770 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.a 1399 to 1856 11 to 468       458/468
(97 %)
6 diff
(98.8 %id)
BU183732 melanotic melanoma, skin SAR1AandTYSND1andAIFM2.a 1400 to 2199 1 to 814       814/831
(97 %)
16 diff
(98.1 %id)
AL563204 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized SAR1AandTYSND1andAIFM2.a 1460 to 2552 1075 to 1       1075/1082
(99 %)
14 diff
(98.8 %id)
BM703137 eye, human retina SAR1AandTYSND1andAIFM2.a 1471 to 1920 1 to 450     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
BX396179 Placenta Cot 25-normalized SAR1AandTYSND1andAIFM2.a 1474 to 2529 1050 to 1       1050/1052
(99 %)
37 diff
(96.5 %id)
BF183956 bone marrow, from chronic myelogenous leukemia SAR1AandTYSND1andAIFM2.a 1489 to 2179 1 to 691       691/826
(83 %)
20 diff
(97.6 %id)
BM693889 eye, lens SAR1AandTYSND1andAIFM2.a 1501 to 2119 1 to 619   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 619/619
(100 %)
0 diff
(100 %id)
BI255952 cervical carcinoma cell line, cervix SAR1AandTYSND1andAIFM2.a 1512 to 2332 1 to 840       840/887
(94 %)
44 diff
(95.1 %id)
CD673151 eye, Iris SAR1AandTYSND1andAIFM2.a 1521 to 2025 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
CR989139 T-Lymphocytes SAR1AandTYSND1andAIFM2.a 1544 to 2157 1 to 614       614/614
(100 %)
2 diff
(99.7 %id)
AL526122 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.a 1582 to 2532 956 to 4       953/956
(99 %)
5 diff
(99.5 %id)
BG990405 head_neck SAR1AandTYSND1andAIFM2.a 1593 to 1726 14 to 152       139/154
(90 %)
14 diff
(91.0 %id)
BM670951 eye, lens SAR1AandTYSND1andAIFM2.a 2089 to 2571 500 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 482/482
(100 %)
1 diff
(99.8 %id)
BM664638 eye, human retina SAR1AandTYSND1andAIFM2.a 2148 to 2565 436 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 418/418
(100 %)
0 diff
(100 %id)
AA147213 Pancreas SAR1AandTYSND1andAIFM2.a 2289 to 2566 279 to 1       553/622
(88 %)
70 diff
(88.8 %id)
NM_001040273.1   SAR1AandTYSND1andAIFM2.b 1 to 3484 2 to 3485 exact RefSeq,   3485/3485
(100 %)
0 diff
(100 %id)
DB452742 testis SAR1AandTYSND1andAIFM2.b 22 to 495 1 to 474   tiling clone,   474/474
(100 %)
3 diff
(99.4 %id)
BF724664 eye, Iris SAR1AandTYSND1andAIFM2.b 69 to 422 1 to 354     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 354/354
(100 %)
1 diff
(99.8 %id)
BX393905 Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.b 79 to 870 1 to 788       788/788
(100 %)
7 diff
(99.2 %id)
BC030242 Brain, Lung, Testis, adult, pooled whole SAR1AandTYSND1andAIFM2.b 84 to 2248 1 to 2165 P203L tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2165/2165
(100 %)
3 diff
(99.9 %id)
BM909014 astrocytoma grade IV, cell line, brain SAR1AandTYSND1andAIFM2.b 88 to 435 1 to 348       348/1214
(28 %)
5 diff
(99.6 %id)
BX340906   SAR1AandTYSND1andAIFM2.b 94 to 1108 1 to 1010       1010/1010
(100 %)
17 diff
(98.4 %id)
BQ961485 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.b 95 to 630 1 to 536       536/1028
(52 %)
14 diff
(98.7 %id)
BE887775 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.b 107 to 853 1 to 745       745/783
(95 %)
30 diff
(96.2 %id)
BE890037 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.b 108 to 845 1 to 732   AAA   732/862
(84 %)
19 diff
(97.8 %id)
BG330877 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.b 120 to 877 1 to 759       759/912
(83 %)
25 diff
(97.3 %id)
BG330848 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.b 120 to 860 1 to 740       740/801
(92 %)
18 diff
(97.8 %id)
TI_57150246   SAR1AandTYSND1andAIFM2.b 120 to 938 68 to 892       825/892
(92 %)
6 diff
(99.4 %id)
BI763020 pooled colon, kidney, stomach SAR1AandTYSND1andAIFM2.b 121 to 938 1 to 824       824/824
(100 %)
14 diff
(98.4 %id)
BQ941399 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.b 121 to 622 27 to 533       507/1015
(49 %)
8 diff
(99.3 %id)
TI_44350144   SAR1AandTYSND1andAIFM2.b 121 to 656 111 to 669       559/674
(82 %)
6 diff
(99.2 %id)
TI_44350297   SAR1AandTYSND1andAIFM2.b 121 to 652 143 to 686       544/691
(78 %)
29 diff
(95.9 %id)
CN298776 embryonic stem cells, DMSO-treated H9 cellline SAR1AandTYSND1andAIFM2.b 126 to 612 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
CN298774 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SAR1AandTYSND1andAIFM2.b 140 to 733 8 to 601   tiling clone,   594/601
(98 %)
6 diff
(99.1 %id)
BX394149 Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.b 141 to 1053 10 to 924       915/1003
(91 %)
19 diff
(98.2 %id)
CN298773 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.b 181 to 599 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
AL562594 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.b 375 to 1284 31 to 939       909/948
(95 %)
14 diff
(98.6 %id)
BX345051 Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.b 375 to 966 1 to 593       593/674
(87 %)
24 diff
(96.5 %id)
TI_57174167   SAR1AandTYSND1andAIFM2.b 401 to 1054 32 to 684       653/686
(95 %)
8 diff
(98.9 %id)
BX282686 brain, medulla SAR1AandTYSND1andAIFM2.b 402 to 905 1 to 504       504/504
(100 %)
0 diff
(100 %id)
BI826555 brain, medulla SAR1AandTYSND1andAIFM2.b 402 to 1054 1 to 652   tiling clone,   652/654
(99 %)
8 diff
(98.8 %id)
BI160553 epithelioid carcinoma cell line, Pancreas SAR1AandTYSND1andAIFM2.b 445 to 1042 1 to 609       609/741
(82 %)
28 diff
(96.3 %id)
BQ961990 epithelioid carcinoma cell line, Pancreas SAR1AandTYSND1andAIFM2.b 448 to 998 1 to 553       553/991
(55 %)
16 diff
(98.4 %id)
BU501792 epithelioid carcinoma cell line, Pancreas SAR1AandTYSND1andAIFM2.b 448 to 1072 1 to 629       629/1065
(59 %)
39 diff
(96.4 %id)
BG489345 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.b 551 to 1314 1 to 759       759/759
(100 %)
18 diff
(97.7 %id)
BE876435 large cell carcinoma, undifferentiated, lung SAR1AandTYSND1andAIFM2.b 567 to 1321 1 to 730   available from MGC,   730/945
(77 %)
38 diff
(96.0 %id)
BM145544 leukopheresis SAR1AandTYSND1andAIFM2.b 644 to 761 1 to 118       118/124
(95 %)
2 diff
(98.4 %id)
BI821179 pooled brain, lung, testis SAR1AandTYSND1andAIFM2.b 645 to 745 606 to 717       643/726
(88 %)
63 diff
(91.4 %id)
DB452309 testis SAR1AandTYSND1andAIFM2.b 673 to 1156 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
CN298772 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.b 798 to 1159 1 to 362       362/362
(100 %)
2 diff
(99.5 %id)
DA201444 brain SAR1AandTYSND1andAIFM2.b 855 to 1438 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
BI771477 pooled lung and spleen SAR1AandTYSND1andAIFM2.b 1090 to 1500 1 to 412       412/412
(100 %)
2 diff
(99.6 %id)
TI_57182866   SAR1AandTYSND1andAIFM2.b 1090 to 1779 34 to 736       703/738
(95 %)
28 diff
(96.3 %id)
BM553590 duodenal adenocarcinoma, cell line, small intestine SAR1AandTYSND1andAIFM2.b 1281 to 2230 1 to 958       958/1014
(94 %)
26 diff
(97.5 %id)
BX393904 Neuroblastoma Cot 25-normalized SAR1AandTYSND1andAIFM2.b 1383 to 2189 834 to 28       807/834
(96 %)
0 diff
(100 %id)
BF724663 eye, Iris SAR1AandTYSND1andAIFM2.b 1661 to 2248 604 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 588/588
(100 %)
0 diff
(100 %id)
BM694384 eye, RPE and Choroid SAR1AandTYSND1andAIFM2.c 1 to 360 1 to 360   tiling clone, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 360/360
(100 %)
1 diff
(99.8 %id)
AF506757   SAR1AandTYSND1andAIFM2.c 100 to 1633 1 to 1534 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1534/1534
(100 %)
1 diff
(100.0 %id)
NM_032797.4   SAR1AandTYSND1andAIFM2.c 100 to 3339 1 to 3240 exact RefSeq,   3240/3240
(100 %)
0 diff
(100 %id)
CN263241 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SAR1AandTYSND1andAIFM2.c 178 to 429 1 to 251       251/251
(100 %)
2 diff
(99.3 %id)
DA500665 brain SAR1AandTYSND1andAIFM2.c 184 to 711 2 to 523   capped   522/522
(100 %)
3 diff
(99.5 %id)
BP295890   SAR1AandTYSND1andAIFM2.c 184 to 765 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB228616 trachea SAR1AandTYSND1andAIFM2.c 185 to 746 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA445227 tongue, tumor tissue SAR1AandTYSND1andAIFM2.c 186 to 759 2 to 581   capped   580/580
(100 %)
3 diff
(99.5 %id)
DA461741 tongue, tumor tissue SAR1AandTYSND1andAIFM2.c 186 to 680 2 to 502   capped   501/501
(100 %)
4 diff
(99.3 %id)
DA915141   SAR1AandTYSND1andAIFM2.c 186 to 734 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
CX164279 human embryonic stem cells differentiated toan early endodermal cell type SAR1AandTYSND1andAIFM2.c 193 to 992 1 to 800       800/800
(100 %)
0 diff
(100 %id)
BG285370 adenocarcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.c 197 to 904 1 to 706       706/710
(99 %)
6 diff
(99.2 %id)
BU501167 eye, normal pigmented retinal epithelium SAR1AandTYSND1andAIFM2.c 202 to 715 1 to 525       525/1310
(40 %)
16 diff
(98.8 %id)
DA129866 alzheimer cortex SAR1AandTYSND1andAIFM2.c 208 to 745 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA622885 Kidney SAR1AandTYSND1andAIFM2.c 209 to 796 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA395869 thalamus SAR1AandTYSND1andAIFM2.c 210 to 749 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
CF126913 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.c 216 to 985 1 to 768       768/768
(100 %)
2 diff
(99.8 %id)
TI_154189989   SAR1AandTYSND1andAIFM2.c 216 to 1074 51 to 900       850/992
(85 %)
15 diff
(98.5 %id)
DB154775 thymus SAR1AandTYSND1andAIFM2.c 218 to 577 2 to 360   capped   359/364
(98 %)
1 diff
(99.8 %id)
DA281701 corpus callosum SAR1AandTYSND1andAIFM2.c 219 to 759 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA995310 synovial membrane tissue from rheumatioidarthritis SAR1AandTYSND1andAIFM2.c 220 to 741 2 to 530   capped   529/529
(100 %)
4 diff
(99.3 %id)
AK027403   SAR1AandTYSND1andAIFM2.c 221 to 3339 1 to 3119 exact tiling clone, available from FLJ,   3119/3119
(100 %)
3 diff
(100.0 %id)
CB150599 cervix, Uterine SAR1AandTYSND1andAIFM2.c 222 to 694 1 to 479       479/479
(100 %)
3 diff
(99.4 %id)
BP260985 small intestine SAR1AandTYSND1andAIFM2.c 222 to 804 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA727372   SAR1AandTYSND1andAIFM2.c 222 to 790 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA010697 adrenal gland SAR1AandTYSND1andAIFM2.c 223 to 787 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA738530   SAR1AandTYSND1andAIFM2.c 223 to 900 2 to 685   capped   684/693
(98 %)
6 diff
(99.2 %id)
DB239834 trachea SAR1AandTYSND1andAIFM2.c 223 to 820 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA426020 colon SAR1AandTYSND1andAIFM2.c 224 to 781 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA556793   SAR1AandTYSND1andAIFM2.c 226 to 771 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CO246587 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.c 233 to 908 1 to 666       668/806
(82 %)
21 diff
(97.4 %id)
DA900491 skeletal muscle SAR1AandTYSND1andAIFM2.c 233 to 787 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BP352946   SAR1AandTYSND1andAIFM2.c 242 to 824 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DA387781 thalamus SAR1AandTYSND1andAIFM2.c 243 to 811 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
BG337490 leiomyosarcoma cell line, uterus SAR1AandTYSND1andAIFM2.c 243 to 1005 1 to 764       764/765
(99 %)
7 diff
(99.1 %id)
BI116754 lung, small cell carcinoma SAR1AandTYSND1andAIFM2.c 243 to 822 13 to 594       582/770
(75 %)
17 diff
(97.8 %id)
BP381770 adipose tissue SAR1AandTYSND1andAIFM2.c 244 to 868 1 to 625       625/625
(100 %)
2 diff
(99.7 %id)
BG425656 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.c 250 to 941 1 to 695       695/697
(99 %)
9 diff
(98.8 %id)
DA917527 small intestine SAR1AandTYSND1andAIFM2.c 250 to 780 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
BG775126 carcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.c 252 to 787 1 to 537   fully sequenced,   537/537
(100 %)
0 diff
(100 %id)
BM043550 carcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.c 252 to 973 1 to 733       731/734
(99 %)
31 diff
(95.8 %id)
BQ233816 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.c 254 to 1090 1 to 841       841/1032
(81 %)
11 diff
(99.0 %id)
BQ920348 carcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.c 254 to 1140 1 to 892       892/959
(93 %)
11 diff
(98.9 %id)
BF351689 head_neck SAR1AandTYSND1andAIFM2.c 257 to 636 400 to 22       379/410
(92 %)
3 diff
(99.3 %id)
DR003580 hippocampus SAR1AandTYSND1andAIFM2.c 258 to 892 8 to 643       636/645
(98 %)
8 diff
(98.8 %id)
CO247067 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.c 271 to 1007 8 to 734       727/818
(88 %)
18 diff
(97.8 %id)
DA490472 brain SAR1AandTYSND1andAIFM2.c 275 to 831 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BC006121 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.c 292 to 1633 1 to 1342 exact available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1342/1342
(100 %)
1 diff
(100.0 %id)
CR622972 HeLa cells Cot 25-normalized SAR1AandTYSND1andAIFM2.c 298 to 1627 1 to 1330 exact tiling clone,   1330/1330
(100 %)
0 diff
(100 %id)
AL556311 placenta SAR1AandTYSND1andAIFM2.c 298 to 1128 1 to 831       831/831
(100 %)
0 diff
(100 %id)
AL555902 placenta SAR1AandTYSND1andAIFM2.c 298 to 1144 1 to 847       847/847
(100 %)
1 diff
(99.9 %id)
BM458170 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.c 599 to 1548 1 to 961       961/1030
(93 %)
31 diff
(97.0 %id)
BX398966 Placenta Cot 25-normalized SAR1AandTYSND1andAIFM2.c 610 to 1602 984 to 1       984/987
(99 %)
32 diff
(96.8 %id)
TI_227713776   SAR1AandTYSND1andAIFM2.c 615 to 1626 1077 to 82   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 996/1014
(98 %)
34 diff
(96.7 %id)
AL578283 placenta SAR1AandTYSND1andAIFM2.c 643 to 1528 904 to 19       886/904
(98 %)
4 diff
(99.6 %id)
TI_227715622   SAR1AandTYSND1andAIFM2.c 728 to 1626 969 to 82   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 888/1003
(88 %)
19 diff
(98.2 %id)
BG775899 carcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.c 757 to 1604 859 to 13   fully sequenced,   847/859
(98 %)
4 diff
(99.6 %id)
CF129967 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.c 819 to 1496 7 to 684       678/684
(99 %)
9 diff
(98.7 %id)
TI_154191869   SAR1AandTYSND1andAIFM2.c 819 to 1616 57 to 848       792/1022
(77 %)
19 diff
(98.2 %id)
TI_159706021   SAR1AandTYSND1andAIFM2.c 832 to 1634 949 to 160   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 790/1076
(73 %)
48 diff
(95.6 %id)
BM708372 eye, RPE and Choroid SAR1AandTYSND1andAIFM2.c 861 to 1314 1 to 454   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 454/454
(100 %)
1 diff
(99.8 %id)
CD742610 Alveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 884 to 1626 760 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 742/742
(100 %)
3 diff
(99.6 %id)
BQ001240 lung, Metastatic Chondrosarcoma SAR1AandTYSND1andAIFM2.c 902 to 1626 743 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 725/725
(100 %)
3 diff
(99.6 %id)
CB528374 Aveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 903 to 1633 747 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 731/731
(100 %)
1 diff
(99.9 %id)
TI_149289427   SAR1AandTYSND1andAIFM2.c 912 to 1626 800 to 86   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 715/716
(99 %)
4 diff
(99.5 %id)
CB528464 Aveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 915 to 1633 728 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 712/713
(99 %)
15 diff
(97.9 %id)
CD366742 Alveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 918 to 1626 727 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 709/709
(100 %)
1 diff
(99.9 %id)
BG575710 breast, mammary adenocarcinoma, cell line SAR1AandTYSND1andAIFM2.c 947 to 1613 1 to 667       667/669
(99 %)
3 diff
(99.6 %id)
BQ000876 lung, Metastatic Chondrosarcoma SAR1AandTYSND1andAIFM2.c 962 to 1626 683 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 665/665
(100 %)
3 diff
(99.6 %id)
BU730593 eye, RPE and Choroid SAR1AandTYSND1andAIFM2.c 974 to 1626 671 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 653/653
(100 %)
7 diff
(99.0 %id)
CA503159 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.c 975 to 1626 668 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 650/666
(97 %)
3 diff
(99.6 %id)
BX389985   SAR1AandTYSND1andAIFM2.c 1001 to 1627 1 to 624       624/624
(100 %)
11 diff
(98.3 %id)
BX389984   SAR1AandTYSND1andAIFM2.c 1009 to 1627 1 to 615       615/615
(100 %)
6 diff
(99.1 %id)
BQ224528 melanotic melanoma, skin SAR1AandTYSND1andAIFM2.c 1020 to 1893 1 to 878       878/878
(100 %)
16 diff
(98.2 %id)
BU681595 lung SAR1AandTYSND1andAIFM2.c 1038 to 1626 608 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 590/590
(100 %)
2 diff
(99.7 %id)
CB529995 Aveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 1038 to 1626 607 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 589/589
(100 %)
13 diff
(97.8 %id)
BM989119 Bone, Subchondral Bone SAR1AandTYSND1andAIFM2.c 1040 to 1633 612 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 594/594
(100 %)
2 diff
(99.7 %id)
DB342983 thymus SAR1AandTYSND1andAIFM2.c 1045 to 1626 582 to 1       582/582
(100 %)
1 diff
(99.9 %id)
BQ957278 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.c 1056 to 1982 23 to 965       884/984
(89 %)
34 diff
(96.6 %id)
BI259212 cervical carcinoma cell line, cervix SAR1AandTYSND1andAIFM2.c 1070 to 1768 1 to 699       699/699
(100 %)
1 diff
(99.9 %id)
DB336229 testis SAR1AandTYSND1andAIFM2.c 1080 to 1633 554 to 1       554/554
(100 %)
1 diff
(99.9 %id)
CA748688 Alveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 1084 to 1633 566 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 550/550
(100 %)
1 diff
(99.9 %id)
BG027268 Bone, osteosarcoma, cell line SAR1AandTYSND1andAIFM2.c 1123 to 1635 1 to 514       514/529
(97 %)
2 diff
(99.7 %id)
AI861904 colon, colon tumor, RER+ SAR1AandTYSND1andAIFM2.c 1132 to 1626 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
BF514763   SAR1AandTYSND1andAIFM2.c 1140 to 1626 504 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 487/487
(100 %)
2 diff
(99.6 %id)
BF002285 colon, colon tumor, RER+ SAR1AandTYSND1andAIFM2.c 1144 to 1634 492 to 2       491/492
(99 %)
0 diff
(100 %id)
AI492077 B-cell, chronic lymphotic leukemia SAR1AandTYSND1andAIFM2.c 1149 to 1625 477 to 1       477/477
(100 %)
5 diff
(99.0 %id)
DA812495 ovary, tumor tissue SAR1AandTYSND1andAIFM2.c 1169 to 1746 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BE999975 colon, colon tumor, RER+ SAR1AandTYSND1andAIFM2.c 1184 to 1626 460 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 444/444
(100 %)
4 diff
(99.1 %id)
AI393971 B-cell, chronic lymphotic leukemia SAR1AandTYSND1andAIFM2.c 1191 to 1634 450 to 7       444/450
(98 %)
0 diff
(100 %id)
AI685521 Prostate SAR1AandTYSND1andAIFM2.c 1192 to 1634 447 to 5       443/447
(99 %)
0 diff
(100 %id)
AI983396 colon, colonic mucosa from 3 patients with Crohn'sdisease SAR1AandTYSND1andAIFM2.c 1206 to 1627 424 to 3       422/424
(99 %)
2 diff
(99.6 %id)
AA631592 lung, lung tumor SAR1AandTYSND1andAIFM2.c 1210 to 1627 421 to 3       419/421
(99 %)
4 diff
(99.1 %id)
AI270335 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SAR1AandTYSND1andAIFM2.c 1213 to 1634 428 to 7       422/428
(98 %)
0 diff
(100 %id)
AW294884   SAR1AandTYSND1andAIFM2.c 1213 to 1633 436 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 421/421
(100 %)
3 diff
(99.3 %id)
BI859616 breast, mammary adenocarcinoma, cell line SAR1AandTYSND1andAIFM2.c 1213 to 1633 11 to 431   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 421/431
(97 %)
6 diff
(98.7 %id)
TI_57190659   SAR1AandTYSND1andAIFM2.c 1213 to 1633 98 to 518   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 421/431
(97 %)
6 diff
(98.7 %id)
CA314960 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.c 1236 to 1626 409 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 391/391
(100 %)
0 diff
(100 %id)
CA308564 Alveolar Macrophage, lung SAR1AandTYSND1andAIFM2.c 1239 to 1633 413 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 395/395
(100 %)
1 diff
(99.8 %id)
BU732124 eye, RPE and Choroid SAR1AandTYSND1andAIFM2.c 1253 to 1626 392 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 374/374
(100 %)
0 diff
(100 %id)
T47788.
matches multiple genes
fetal spleen, Spleen SAR1AandTYSND1andAIFM2.c 1267 to 1626 358 to 1     also hits gene DUSP26 358/358
(100 %)
7 diff
(98.1 %id)
BU588313 mixed (pool of 40 RNAs) SAR1AandTYSND1andAIFM2.c 1283 to 1590 39 to 347       309/376
(82 %)
5 diff
(98.7 %id)
AI765124 colon, colon tumor, RER+ SAR1AandTYSND1andAIFM2.c 1289 to 1634 351 to 6       346/360
(96 %)
0 diff
(100 %id)
BF198007 skin, normal, 4 pooled samples SAR1AandTYSND1andAIFM2.c 1315 to 1633 319 to 1       319/319
(100 %)
0 diff
(100 %id)
BF514177   SAR1AandTYSND1andAIFM2.c 1387 to 1634 264 to 17       248/289
(85 %)
0 diff
(100 %id)
AW296831   SAR1AandTYSND1andAIFM2.c 1389 to 1628 255 to 16   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 240/240
(100 %)
0 diff
(100 %id)
FN166096 breast carcinoma SAR1AandTYSND1andAIFM2.c 1495 to 1595 102 to 1     Submitted on the opposite strand 102/102
(100 %)
2 diff
(98.1 %id)
DA865603 Prostate SAR1AandTYSND1andAIFM2.c 1515 to 2031 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
BQ278582 adenocarcinoma, cell line, breast SAR1AandTYSND1andAIFM2.c 1588 to 2520 12 to 959   tiling clone,   948/1051
(90 %)
33 diff
(96.9 %id)
DA824073 pericardium SAR1AandTYSND1andAIFM2.c 1589 to 2146 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AL578600 placenta SAR1AandTYSND1andAIFM2.c 2355 to 3276 948 to 29       920/948
(97 %)
0 diff
(100 %id)
DB329573 Prostate SAR1AandTYSND1andAIFM2.c 2836 to 3339 505 to 2       504/505
(99 %)
0 diff
(100 %id)
DB324502   SAR1AandTYSND1andAIFM2.c 2885 to 3339 468 to 1       468/542
(86 %)
13 diff
(97.7 %id)
DB371872 ovary, tumor tissue SAR1AandTYSND1andAIFM2.c 2885 to 3339 465 to 1       465/471
(98 %)
7 diff
(98.6 %id)
BP331371 rectum SAR1AandTYSND1andAIFM2.d 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
BP285108 lung SAR1AandTYSND1andAIFM2.d 2 to 580 1 to 580       580/582
(99 %)
11 diff
(98.2 %id)
DA199296 brain SAR1AandTYSND1andAIFM2.d 3 to 544 2 to 549   capped   548/548
(100 %)
4 diff
(99.3 %id)
BP297655   SAR1AandTYSND1andAIFM2.d 36 to 614 1 to 581       581/581
(100 %)
4 diff
(99.4 %id)
DA449847 tongue, tumor tissue SAR1AandTYSND1andAIFM2.d 37 to 599 2 to 566   capped   565/565
(100 %)
4 diff
(99.3 %id)
DA722197   SAR1AandTYSND1andAIFM2.d 40 to 605 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BM545698 ovary (pool of 3) SAR1AandTYSND1andAIFM2.d 54 to 749 125 to 825       701/1064
(65 %)
17 diff
(98.5 %id)
CN263240 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SAR1AandTYSND1andAIFM2.d 60 to 731 13 to 684       672/684
(98 %)
6 diff
(99.2 %id)
CB269021 adipose SAR1AandTYSND1andAIFM2.d 65 to 639 1 to 578       578/661
(87 %)
20 diff
(97.0 %id)
AW239408 lung, cell line SAR1AandTYSND1andAIFM2.d 70 to 394 1 to 325       325/325
(100 %)
0 diff
(100 %id)
AL702599 human skeletal muscle SAR1AandTYSND1andAIFM2.d 74 to 575 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
BP271636   SAR1AandTYSND1andAIFM2.d 81 to 706 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
AF337957   SAR1AandTYSND1andAIFM2.d 116 to 2685 1 to 2562 exact tiling clone,   2562/2562
(100 %)
13 diff
(99.5 %id)
DA173429 amygdala SAR1AandTYSND1andAIFM2.d 120 to 682 17 to 579   capped   566/578
(97 %)
6 diff
(99.0 %id)
TI_154195511   SAR1AandTYSND1andAIFM2.d 127 to 1105 4 to 973       970/1072
(90 %)
21 diff
(98.1 %id)
TI_1948123424   SAR1AandTYSND1andAIFM2.d 129 to 671 126 to 668   fully sequenced,   543/668
(81 %)
6 diff
(99.2 %id)
TI_1948123599   SAR1AandTYSND1andAIFM2.d 129 to 710 127 to 708   fully sequenced,   582/708
(82 %)
6 diff
(99.2 %id)
TI_1948123767   SAR1AandTYSND1andAIFM2.d 129 to 671 124 to 666   fully sequenced,   543/666
(81 %)
6 diff
(99.1 %id)
TI_1948123933   SAR1AandTYSND1andAIFM2.d 129 to 710 137 to 718   fully sequenced,   582/718
(81 %)
6 diff
(99.2 %id)
TI_154196663   SAR1AandTYSND1andAIFM2.d 129 to 906 1 to 774       774/1050
(73 %)
22 diff
(98.0 %id)
BE273331 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.d 131 to 751 1 to 620       620/742
(83 %)
16 diff
(97.9 %id)
CD514797 White Matter SAR1AandTYSND1andAIFM2.d 160 to 1011 1 to 857       857/857
(100 %)
8 diff
(99.1 %id)
BU538375 adenocarcinoma, cell line, breast SAR1AandTYSND1andAIFM2.d 209 to 1143 1 to 938       938/940
(99 %)
6 diff
(99.4 %id)
BQ635940 eye, retina SAR1AandTYSND1andAIFM2.d 274 to 871 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CD634369   SAR1AandTYSND1andAIFM2.d 317 to 592 8 to 283       276/301
(91 %)
8 diff
(97.4 %id)
CD634370   SAR1AandTYSND1andAIFM2.d 317 to 592 293 to 18       276/300
(92 %)
0 diff
(100 %id)
DA906295   SAR1AandTYSND1andAIFM2.d 333 to 900 2 to 570   capped   567/569
(99 %)
1 diff
(99.9 %id)
DA451970 tongue, tumor tissue SAR1AandTYSND1andAIFM2.d 370 to 953 2 to 586   capped   585/585
(100 %)
3 diff
(99.5 %id)
BG438087 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.d 383 to 1175 1 to 804       801/985
(81 %)
21 diff
(97.9 %id)
BU158922 large cell carcinoma, lung SAR1AandTYSND1andAIFM2.d 388 to 1141 1 to 753   tiling clone,   753/898
(83 %)
9 diff
(99.0 %id)
CO247481 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.d 396 to 919 41 to 562       522/763
(68 %)
22 diff
(97.2 %id)
BE839030 prostate_normal SAR1AandTYSND1andAIFM2.d 400 to 748 379 to 30       350/380
(92 %)
5 diff
(98.7 %id)
BE839032 prostate_normal SAR1AandTYSND1andAIFM2.d 400 to 751 358 to 10       349/368
(94 %)
3 diff
(99.2 %id)
BF766545 colon_est SAR1AandTYSND1andAIFM2.d 406 to 601 213 to 21     Submitted on the opposite strand 193/220
(87 %)
5 diff
(97.8 %id)
BF330240 breast_normal SAR1AandTYSND1andAIFM2.d 435 to 897 1 to 467       467/468
(99 %)
14 diff
(97.1 %id)
TI_57190233   SAR1AandTYSND1andAIFM2.d 444 to 1293 52 to 901       850/850
(100 %)
8 diff
(99.1 %id)
BI856827 breast, mammary adenocarcinoma, cell line SAR1AandTYSND1andAIFM2.d 445 to 1293 1 to 849       849/849
(100 %)
8 diff
(99.1 %id)
BQ669710 epidermoid carcinoma, cell line, salivary gland SAR1AandTYSND1andAIFM2.d 488 to 1192 1 to 707       707/943
(74 %)
22 diff
(97.7 %id)
CD643465 Embryonic Stem cells SAR1AandTYSND1andAIFM2.d 508 to 1207 43 to 737       695/828
(83 %)
15 diff
(98.2 %id)
BG250276 adenocarcinoma, cell line, Liver SAR1AandTYSND1andAIFM2.d 549 to 1245 26 to 719       692/940
(73 %)
21 diff
(97.8 %id)
AA320893 adipose tissue, white SAR1AandTYSND1andAIFM2.d 591 to 846 1 to 256       256/256
(100 %)
0 diff
(100 %id)
AW961592   SAR1AandTYSND1andAIFM2.d 592 to 1197 1 to 606       606/607
(99 %)
7 diff
(98.9 %id)
TI_1948123425   SAR1AandTYSND1andAIFM2.d 610 to 1254 771 to 127   fully sequenced,   645/771
(83 %)
1 diff
(99.9 %id)
TI_1948123768   SAR1AandTYSND1andAIFM2.d 610 to 1254 771 to 127   fully sequenced,   645/771
(83 %)
1 diff
(99.9 %id)
AI143457 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SAR1AandTYSND1andAIFM2.d 653 to 1150 11 to 508     Submitted on the opposite strand 496/508
(97 %)
11 diff
(97.9 %id)
TI_1948123600   SAR1AandTYSND1andAIFM2.d 680 to 1254 701 to 127   fully sequenced,   575/701
(82 %)
1 diff
(99.9 %id)
TI_1948123934   SAR1AandTYSND1andAIFM2.d 680 to 1254 704 to 127   fully sequenced,   578/704
(82 %)
3 diff
(99.6 %id)
AV748228 Pituitary SAR1AandTYSND1andAIFM2.d 735 to 1094 1 to 357       360/359
(100 %)
4 diff
(98.9 %id)
AF147074 breast SAR1AandTYSND1andAIFM2.d 1851 to 1957 14 to 121       108/121
(89 %)
6 diff
(95.1 %id)
AF147075 breast SAR1AandTYSND1andAIFM2.d 1988 to 2123 136 to 1       136/137
(99 %)
1 diff
(99.3 %id)
CV407167 breast SAR1AandTYSND1andAIFM2.e 1 to 510 1 to 514   tiling clone,   514/514
(100 %)
13 diff
(97.5 %id)
AK127353 hippocampus SAR1AandTYSND1andAIFM2.e 166 to 5159 1 to 4995 exact tiling clone, available from FLJ,   4995/4995
(100 %)
4 diff
(100.0 %id)
CA405487 adipose SAR1AandTYSND1andAIFM2.e 3469 to 3677 1 to 213       213/219
(97 %)
18 diff
(91.8 %id)
BF373086 prostate_tumor SAR1AandTYSND1andAIFM2.e 3497 to 3860 375 to 11       365/383
(95 %)
0 diff
(100 %id)
BF915880 uterus_tumor SAR1AandTYSND1andAIFM2.e 3587 to 3697 111 to 1     Submitted on the opposite strand 111/111
(100 %)
0 diff
(100 %id)
CB127015 cervix, Uterine SAR1AandTYSND1andAIFM2.e 3816 to 4351 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
BM990964 lung, Lung Focal Fibrosis SAR1AandTYSND1andAIFM2.e 3892 to 4507 1 to 615     Submitted on the opposite strand 615/615
(100 %)
4 diff
(99.4 %id)
CB215085 normal endometrium, late proliferativephase, cycle day 13, uterus SAR1AandTYSND1andAIFM2.e 3930 to 4568 1 to 639       639/639
(100 %)
0 diff
(100 %id)
CB269498 adipose SAR1AandTYSND1andAIFM2.e 4136 to 4559 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
BF884722 lung_tumor SAR1AandTYSND1andAIFM2.e 4155 to 4662 1 to 511       511/511
(100 %)
12 diff
(97.7 %id)
BI014740 lung_tumor SAR1AandTYSND1andAIFM2.e 4155 to 4625 33 to 499       467/499
(93 %)
6 diff
(98.8 %id)
BM695739 eye, optic nerve SAR1AandTYSND1andAIFM2.e 4169 to 4699 1 to 530   fully sequenced, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 530/530
(100 %)
1 diff
(99.9 %id)
BX283086 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.e 4249 to 4740 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BG325254 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.e 4249 to 4829 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
BG422019 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.e 4249 to 5002 1 to 757       757/945
(80 %)
41 diff
(95.7 %id)
BE274002 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.e 4269 to 4743 1 to 475       475/562
(84 %)
2 diff
(99.7 %id)
BM833605 stomach SAR1AandTYSND1andAIFM2.e 4373 to 4857 1 to 485       485/485
(100 %)
3 diff
(99.4 %id)
BU625770 cell lines, Enchondroma SAR1AandTYSND1andAIFM2.e 4482 to 5159 694 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 676/676
(100 %)
4 diff
(99.5 %id)
BQ183743 Knee, Osteoarthritic Cartilage SAR1AandTYSND1andAIFM2.e 4535 to 5159 644 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 626/626
(100 %)
1 diff
(99.9 %id)
AI922797 adenocarcinoma, Pancreas SAR1AandTYSND1andAIFM2.e 4643 to 5166 530 to 7   tiling clone,   524/530
(98 %)
0 diff
(100 %id)
H43475 breast SAR1AandTYSND1andAIFM2.e 4654 to 5067 11 to 427       417/501
(83 %)
12 diff
(97.7 %id)
BM665110 eye, optic nerve SAR1AandTYSND1andAIFM2.e 4669 to 5159 509 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 491/491
(100 %)
0 diff
(100 %id)
DW411410 Liver SAR1AandTYSND1andAIFM2.e 4681 to 4993 17 to 329       313/329
(95 %)
6 diff
(98.2 %id)
AA701278 liver and spleen SAR1AandTYSND1andAIFM2.e 4703 to 5156 451 to 1       451/451
(100 %)
6 diff
(98.7 %id)
AW005500 colon SAR1AandTYSND1andAIFM2.e 4706 to 5159 465 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 454/454
(100 %)
3 diff
(99.4 %id)
AA677484 liver and spleen SAR1AandTYSND1andAIFM2.e 4738 to 5156 416 to 1       416/416
(100 %)
4 diff
(99.1 %id)
AI056644 liver and spleen SAR1AandTYSND1andAIFM2.e 4754 to 5156 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AA724584 pooled SAR1AandTYSND1andAIFM2.e 4767 to 5162 400 to 7       394/400
(98 %)
0 diff
(100 %id)
AI273631 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SAR1AandTYSND1andAIFM2.e 4778 to 5159 405 to 24   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 382/382
(100 %)
10 diff
(97.4 %id)
F21398 pectoral muscle (after mastectomy) SAR1AandTYSND1andAIFM2.e 4796 to 5162 3 to 376       374/381
(98 %)
11 diff
(97.2 %id)
AI216265 carcinoid, lung SAR1AandTYSND1andAIFM2.e 4803 to 5162 364 to 6       359/364
(98 %)
0 diff
(100 %id)
AI763345 colon, colon tumor, RER+ SAR1AandTYSND1andAIFM2.e 4828 to 5159 349 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 332/332
(100 %)
8 diff
(97.6 %id)
AW016581   SAR1AandTYSND1andAIFM2.e 4847 to 5163 330 to 14   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
BE048343 Kidney SAR1AandTYSND1andAIFM2.e 4849 to 5162 315 to 2       314/315
(99 %)
0 diff
(100 %id)
AI933565 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SAR1AandTYSND1andAIFM2.e 4877 to 5159 282 to 1       282/282
(100 %)
4 diff
(98.6 %id)
CB959135 Pooled-Glandular SAR1AandTYSND1andAIFM2.e 4888 to 5159 1 to 272   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 272/272
(100 %)
4 diff
(98.6 %id)
BG424074 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.f 1 to 721 1 to 732   tiling clone,   732/1026
(71 %)
21 diff
(98.0 %id)
TI_182940346   SAR1AandTYSND1andAIFM2.f 295 to 1002 767 to 60   tiling clone,   708/1085
(65 %)
1 diff
(100.0 %id)
TI_227717779   SAR1AandTYSND1andAIFM2.f 295 to 1002 773 to 66       708/1105
(64 %)
4 diff
(99.7 %id)
DB097901 testis SAR1AandTYSND1andAIFM2.g 1 to 588 2 to 589   tiling clone, capped   588/588
(100 %)
0 diff
(100 %id)
DB025775 testis SAR1AandTYSND1andAIFM2.g 9 to 557 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB088307 testis SAR1AandTYSND1andAIFM2.g 133 to 669 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
BX537621 esophagus tumor SAR1AandTYSND1andAIFM2.g 570 to 4446 1 to 3877   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 3877/3877
(100 %)
5 diff
(99.9 %id)
DB287996 uterus SAR1AandTYSND1andAIFM2.g 878 to 1398 2 to 522   capped   521/521
(100 %)
0 diff
(100 %id)
DA460834 tongue, tumor tissue SAR1AandTYSND1andAIFM2.h 1 to 562 2 to 563   tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
BM545749 ovary (pool of 3) SAR1AandTYSND1andAIFM2.h 556 to 1125 343 to 915   tiling clone,   573/981
(58 %)
33 diff
(96.7 %id)
BG722159 testis SAR1AandTYSND1andAIFM2.i 1 to 721 1 to 722   tiling clone,   722/722
(100 %)
5 diff
(99.4 %id)
BF830187 head_normal SAR1AandTYSND1andAIFM2.i 420 to 963 557 to 14   tiling clone, Submitted on the opposite strand 544/558
(97 %)
4 diff
(99.3 %id)
BP247476 Kidney SAR1AandTYSND1andAIFM2.j 1 to 580 1 to 581   tiling clone,   581/583
(99 %)
7 diff
(98.8 %id)
DA299387 hippocampus SAR1AandTYSND1andAIFM2.j 2 to 553 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB080654 testis SAR1AandTYSND1andAIFM2.j 2 to 581 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA906900   SAR1AandTYSND1andAIFM2.j 3 to 578 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BP372457 umbilical cord SAR1AandTYSND1andAIFM2.j 3 to 582 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DA536226 heart SAR1AandTYSND1andAIFM2.j 4 to 605 2 to 604   capped   603/603
(100 %)
2 diff
(99.7 %id)
DA577071   SAR1AandTYSND1andAIFM2.j 4 to 571 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BM835777 stomach SAR1AandTYSND1andAIFM2.j 12 to 512 1 to 501       501/501
(100 %)
0 diff
(100 %id)
AF318066 bone marrow SAR1AandTYSND1andAIFM2.j 56 to 2881 1 to 2820 exact tiling clone, AAA   2820/2820
(100 %)
30 diff
(99.0 %id)
TI_154179147   SAR1AandTYSND1andAIFM2.j 1795 to 2639 79 to 911       833/953
(87 %)
16 diff
(98.4 %id)
TI_154179153   SAR1AandTYSND1andAIFM2.j 1795 to 2635 79 to 897       819/899
(91 %)
29 diff
(96.8 %id)
BE002769 breast_normal SAR1AandTYSND1andAIFM2.j 1804 to 2240 437 to 2   tiling clone, AAA Submitted on the opposite strand 436/518
(84 %)
0 diff
(100 %id)
TI_149305777   SAR1AandTYSND1andAIFM2.j 1804 to 2684 70 to 938     Submitted on the opposite strand 869/1031
(84 %)
20 diff
(98.1 %id)
CF146659 CNCAP(3)T-225 cell line, Prostate SAR1AandTYSND1andAIFM2.j 1806 to 2532 19 to 744       726/744
(97 %)
6 diff
(99.2 %id)
CF146664 CNCAP(3)T-225 cell line, Prostate SAR1AandTYSND1andAIFM2.j 1806 to 2442 19 to 654       636/654
(97 %)
6 diff
(99.1 %id)
BF033487 adenocarcinoma, ovary SAR1AandTYSND1andAIFM2.j 1808 to 2113 306 to 1   AAA Submitted on the opposite strand 306/306
(100 %)
1 diff
(99.7 %id)
BU686076 lung, Primary Lung Epithelial Cells SAR1AandTYSND1andAIFM2.j 1811 to 2446 1 to 636     Submitted on the opposite strand 636/638
(99 %)
3 diff
(99.6 %id)
EB388518 eye, optic nerve SAR1AandTYSND1andAIFM2.j 1868 to 2660 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
W73467 heart SAR1AandTYSND1andAIFM2.j 1873 to 2293 1 to 421       421/421
(100 %)
3 diff
(99.3 %id)
BG610883 adenocarcinoma, Prostate SAR1AandTYSND1andAIFM2.j 1880 to 2646 1 to 770       770/770
(100 %)
9 diff
(98.9 %id)
BU172669 melanotic melanoma, skin SAR1AandTYSND1andAIFM2.j 1888 to 2636 1 to 767       767/926
(82 %)
30 diff
(96.8 %id)
CR600689 Neuroblastoma Cot 10-normalized SAR1AandTYSND1andAIFM2.j 1932 to 2862 1 to 931   tiling clone,   931/931
(100 %)
0 diff
(100 %id)
BM820067 stomach SAR1AandTYSND1andAIFM2.j 1951 to 2535 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
TI_154109461   SAR1AandTYSND1andAIFM2.j 1966 to 2881 989 to 91   AAA   899/990
(90 %)
20 diff
(98.0 %id)
BI050893 placenta_normal SAR1AandTYSND1andAIFM2.j 1969 to 2107 140 to 1       140/159
(88 %)
7 diff
(95.6 %id)
BG619462 placenta SAR1AandTYSND1andAIFM2.j 1969 to 2625 1 to 659       659/660
(99 %)
5 diff
(99.3 %id)
BG014390 placenta_normal SAR1AandTYSND1andAIFM2.j 1970 to 2123 174 to 22       153/174
(87 %)
0 diff
(100 %id)
BF526728 brain, glioblastoma with EGFR amplification SAR1AandTYSND1andAIFM2.j 1975 to 2653 1 to 679       679/681
(99 %)
10 diff
(98.6 %id)
CF128259 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.j 1982 to 2664 1 to 684       684/687
(99 %)
7 diff
(99.0 %id)
CB858022 anterior tongue, pooled SAR1AandTYSND1andAIFM2.j 1988 to 2539 582 to 32     Submitted on the opposite strand 551/582
(94 %)
0 diff
(100 %id)
W73347 heart SAR1AandTYSND1andAIFM2.j 2486 to 2881 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
NM_001142648.1   SAR1AandTYSND1andAIFM2.k 1 to 3063 2 to 3064 exact RefSeq, AAA   3064/3064
(100 %)
0 diff
(100 %id)
DB216796 trachea SAR1AandTYSND1andAIFM2.k 1 to 555 2 to 556   tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
BM928339 brain SAR1AandTYSND1andAIFM2.k 6 to 908 13 to 933 N162D L165P K166E Q184E Y186L ...     921/1116
(82 %)
39 diff
(96.6 %id)
FN141856 breast carcinoma SAR1AandTYSND1andAIFM2.k 15 to 95 1 to 83       83/85
(97 %)
6 diff
(93.0 %id)
DA411450 thalamus SAR1AandTYSND1andAIFM2.k 27 to 587 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
BG327663 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.k 31 to 711 1 to 680       680/681
(99 %)
2 diff
(99.8 %id)
BQ941426 sciatic nerve SAR1AandTYSND1andAIFM2.k 52 to 836 1 to 784 Y196I I197L D198T tiling clone,   784/790
(99 %)
5 diff
(99.4 %id)
DA496821 brain SAR1AandTYSND1andAIFM2.k 58 to 627 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB268096 uterus SAR1AandTYSND1andAIFM2.k 58 to 511 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
BQ003567 Chondrosarcoma, Left Pelvis SAR1AandTYSND1andAIFM2.k 139 to 833 712 to 19 exact AAA   694/694
(100 %)
1 diff
(99.9 %id)
BU570299 testis SAR1AandTYSND1andAIFM2.k 162 to 893 1 to 738 R183K G185S     738/774
(95 %)
16 diff
(98.0 %id)
BQ003860 Chondrosarcoma, Left Pelvis SAR1AandTYSND1andAIFM2.k 174 to 847 692 to 19 F3V F5C AAA   674/674
(100 %)
2 diff
(99.8 %id)
TI_149291485   SAR1AandTYSND1andAIFM2.k 186 to 847 741 to 80 F5X AAA   662/925
(71 %)
0 diff
(100 %id)
BM974100 lung SAR1AandTYSND1andAIFM2.k 186 to 847 680 to 19 F5X AAA   662/696
(95 %)
0 diff
(100 %id)
BX374612 Neuroblastoma Cot 10-normalized SAR1AandTYSND1andAIFM2.k 187 to 856 1 to 670 exact     670/670
(100 %)
0 diff
(100 %id)
CX756602 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SAR1AandTYSND1andAIFM2.k 187 to 871 49 to 731 V109M S194F   Submitted on the opposite strand 632/734
(86 %)
55 diff
(92.6 %id)
CX754124 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SAR1AandTYSND1andAIFM2.k 187 to 851 37 to 698 V109M   Submitted on the opposite strand 611/698
(87 %)
51 diff
(92.7 %id)
BM796759 Ascites, stomach SAR1AandTYSND1andAIFM2.k 189 to 711 1 to 523       523/523
(100 %)
0 diff
(100 %id)
CB270682 adipose SAR1AandTYSND1andAIFM2.k 195 to 543 1 to 349       349/349
(100 %)
0 diff
(100 %id)
TI_1948083898   SAR1AandTYSND1andAIFM2.k 195 to 798 738 to 134       605/1110
(54 %)
21 diff
(98.2 %id)
CR533492   SAR1AandTYSND1andAIFM2.k 203 to 921 1 to 719 D104G N162D Q184R     719/719
(100 %)
5 diff
(99.4 %id)
CV026180 mixed SAR1AandTYSND1andAIFM2.k 203 to 798 1 to 596       596/616
(96 %)
1 diff
(99.9 %id)
AI553878 anaplastic oligodendroglioma, brain SAR1AandTYSND1andAIFM2.k 203 to 847 670 to 26 Y9S F12S K27X T158P T164P AAA   645/645
(100 %)
8 diff
(98.8 %id)
CB530037 Aveolar Macrophage, lung SAR1AandTYSND1andAIFM2.k 209 to 838 648 to 19   AAA   630/716
(87 %)
0 diff
(100 %id)
BU929751 placenta SAR1AandTYSND1andAIFM2.k 210 to 882 1 to 674       674/679
(99 %)
5 diff
(99.3 %id)
AA931164 pooled germ cell tumors SAR1AandTYSND1andAIFM2.k 218 to 835 627 to 10       618/627
(98 %)
3 diff
(99.6 %id)
AA628929   SAR1AandTYSND1andAIFM2.k 232 to 847 631 to 17   AAA   615/617
(99 %)
9 diff
(98.6 %id)
TI_154132870   SAR1AandTYSND1andAIFM2.k 257 to 837 696 to 111   AAA   586/774
(75 %)
17 diff
(97.9 %id)
TI_1948084169   SAR1AandTYSND1andAIFM2.k 262 to 798 667 to 130       538/1140
(47 %)
8 diff
(99.3 %id)
AA481571 germinal center B cell SAR1AandTYSND1andAIFM2.k 269 to 687 1 to 419       419/419
(100 %)
0 diff
(100 %id)
CN337778 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.k 309 to 1040 1 to 732       732/732
(100 %)
2 diff
(99.8 %id)
DA861411 placenta SAR1AandTYSND1andAIFM2.k 324 to 878 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AI200872   SAR1AandTYSND1andAIFM2.k 326 to 847 538 to 17   AAA   522/522
(100 %)
0 diff
(100 %id)
DB479605 hippocampus SAR1AandTYSND1andAIFM2.k 349 to 845 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
AA558961 breast SAR1AandTYSND1andAIFM2.k 359 to 847 489 to 1       489/489
(100 %)
0 diff
(100 %id)
BE694122 breast SAR1AandTYSND1andAIFM2.k 374 to 638 271 to 7       265/271
(97 %)
0 diff
(100 %id)
AW878950 ovary SAR1AandTYSND1andAIFM2.k 377 to 488 19 to 130       114/130
(87 %)
7 diff
(94.7 %id)
BF095048 uterus_tumor SAR1AandTYSND1andAIFM2.k 387 to 551 192 to 28       165/192
(85 %)
3 diff
(98.5 %id)
BF909696 uterus_tumor SAR1AandTYSND1andAIFM2.k 387 to 551 1 to 165       165/174
(94 %)
1 diff
(99.5 %id)
CN337774 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SAR1AandTYSND1andAIFM2.k 387 to 872 1 to 486       486/486
(100 %)
0 diff
(100 %id)
AA905973 pooled SAR1AandTYSND1andAIFM2.k 392 to 838 447 to 1       447/447
(100 %)
0 diff
(100 %id)
BI253129 cervical carcinoma cell line, cervix SAR1AandTYSND1andAIFM2.k 428 to 1172 1 to 745       745/1121
(66 %)
10 diff
(99.2 %id)
W24069 senescent fibroblast SAR1AandTYSND1andAIFM2.k 442 to 848 1 to 408       408/415
(98 %)
4 diff
(99.1 %id)
AF086166   SAR1AandTYSND1andAIFM2.k 444 to 847 1 to 404   AAA   404/404
(100 %)
0 diff
(100 %id)
N98998 senescent fibroblast SAR1AandTYSND1andAIFM2.k 445 to 847 425 to 23   AAA   403/413
(97 %)
0 diff
(100 %id)
TI_149292954   SAR1AandTYSND1andAIFM2.k 474 to 1192 796 to 79   AAA   718/718
(100 %)
3 diff
(99.6 %id)
CA425843 cell lines, Chondrosarcoma SAR1AandTYSND1andAIFM2.k 475 to 1160 704 to 19   AAA   686/686
(100 %)
0 diff
(100 %id)
DN919438   SAR1AandTYSND1andAIFM2.k 485 to 837 354 to 2       353/354
(99 %)
12 diff
(96.7 %id)
CF552696 Pooled muscle (cardiac and skeletal) SAR1AandTYSND1andAIFM2.k 494 to 1358 1 to 865       865/865
(100 %)
0 diff
(100 %id)
BM974996 lung SAR1AandTYSND1andAIFM2.k 496 to 1192 713 to 17   AAA   697/697
(100 %)
0 diff
(100 %id)
BU632984 Bone, Subchondral Bone SAR1AandTYSND1andAIFM2.k 501 to 1160 679 to 19   AAA   661/661
(100 %)
1 diff
(99.9 %id)
BP278931   SAR1AandTYSND1andAIFM2.k 507 to 1097 1 to 592       592/592
(100 %)
4 diff
(99.4 %id)
DA147540 amygdala SAR1AandTYSND1andAIFM2.k 544 to 1117 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AI201809 anaplastic oligodendroglioma, brain SAR1AandTYSND1andAIFM2.k 551 to 847 309 to 13   AAA   297/297
(100 %)
0 diff
(100 %id)
AA938505 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.k 568 to 834 267 to 1       267/267
(100 %)
0 diff
(100 %id)
X90541 eye SAR1AandTYSND1andAIFM2.k 593 to 1214 622 to 3       620/626
(99 %)
3 diff
(99.6 %id)
AA938282 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.k 618 to 826 209 to 1       209/209
(100 %)
0 diff
(100 %id)
FN052219 breast carcinoma SAR1AandTYSND1andAIFM2.k 622 to 675 1 to 52       52/52
(100 %)
2 diff
(96.2 %id)
CA392755 eye, RPE/choroid SAR1AandTYSND1andAIFM2.k 647 to 1085 1 to 439       439/439
(100 %)
0 diff
(100 %id)
DR759975 embryonic stem SAR1AandTYSND1andAIFM2.k 660 to 1433 1 to 774   tiling clone,   774/774
(100 %)
0 diff
(100 %id)
CD629850   SAR1AandTYSND1andAIFM2.k 678 to 1392 1 to 710       710/710
(100 %)
12 diff
(98.4 %id)
CD629851   SAR1AandTYSND1andAIFM2.k 681 to 1457 781 to 7       775/784
(98 %)
6 diff
(99.3 %id)
BX389406 Neuroblastoma Cot 10-normalized SAR1AandTYSND1andAIFM2.k 721 to 1488 1 to 775       775/833
(93 %)
43 diff
(94.9 %id)
BG675437 skin SAR1AandTYSND1andAIFM2.k 762 to 1534 1 to 778       778/861
(90 %)
16 diff
(98.2 %id)
DB054461 testis SAR1AandTYSND1andAIFM2.k 810 to 1367 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BE711696 head_neck SAR1AandTYSND1andAIFM2.k 846 to 1156 336 to 30       307/336
(91 %)
0 diff
(100 %id)
AW370293 breast SAR1AandTYSND1andAIFM2.k 855 to 1089 234 to 1       234/235
(99 %)
1 diff
(99.6 %id)
BX646777 Liver SAR1AandTYSND1andAIFM2.k 865 to 1522 1 to 658       658/662
(99 %)
11 diff
(98.4 %id)
BG620008 placenta SAR1AandTYSND1andAIFM2.k 898 to 1684 1 to 803       803/820
(97 %)
18 diff
(97.9 %id)
CU453548 epidermis SAR1AandTYSND1andAIFM2.k 980 to 1155 10 to 185       176/198
(88 %)
1 diff
(99.5 %id)
BE711550 head_neck SAR1AandTYSND1andAIFM2.k 984 to 1160 176 to 1       176/176
(100 %)
1 diff
(99.5 %id)
AL601131   SAR1AandTYSND1andAIFM2.k 1001 to 1675 1 to 676       676/676
(100 %)
2 diff
(99.8 %id)
AA374218 lung SAR1AandTYSND1andAIFM2.k 1056 to 1210 1 to 155       155/155
(100 %)
0 diff
(100 %id)
TI_57149197   SAR1AandTYSND1andAIFM2.k 1136 to 1799 32 to 696       665/696
(95 %)
6 diff
(99.2 %id)
DA599278   SAR1AandTYSND1andAIFM2.k 1184 to 1735 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AW750140 breast SAR1AandTYSND1andAIFM2.k 1287 to 1517 247 to 17       231/248
(93 %)
0 diff
(100 %id)
BM556837 duodenal adenocarcinoma, cell line, small intestine SAR1AandTYSND1andAIFM2.k 1292 to 1985 1 to 692       692/1000
(69 %)
6 diff
(99.4 %id)
BQ086264 Islets of Langerhans, Pancreas SAR1AandTYSND1andAIFM2.k 1292 to 1841 1 to 550       550/550
(100 %)
0 diff
(100 %id)
CK822944 Islets of Langerhans, Pancreas SAR1AandTYSND1andAIFM2.k 1292 to 1891 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BQ959634 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.k 1340 to 1990 1 to 651   tiling clone,   651/655
(99 %)
1 diff
(99.9 %id)
BE939637 uterus_tumor SAR1AandTYSND1andAIFM2.k 1432 to 1667 235 to 2       234/252
(92 %)
0 diff
(100 %id)
TI_149293729   SAR1AandTYSND1andAIFM2.k 1509 to 2258 835 to 90   AAA   746/914
(81 %)
7 diff
(99.3 %id)
CD638432 pooled SAR1AandTYSND1andAIFM2.k 1529 to 2226 1 to 690   tiling clone,   690/692
(99 %)
9 diff
(98.7 %id)
CN337773 embryonic stem cells, DMSO-treated H9 cellline SAR1AandTYSND1andAIFM2.k 1534 to 1949 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BM975262 lung SAR1AandTYSND1andAIFM2.k 1554 to 2258 720 to 17   tiling clone, AAA   704/704
(100 %)
12 diff
(98.3 %id)
AW859045 colon SAR1AandTYSND1andAIFM2.k 1709 to 1892 214 to 33       182/226
(80 %)
0 diff
(100 %id)
C02313   SAR1AandTYSND1andAIFM2.k 2005 to 2219 221 to 7   tiling clone,   215/239
(89 %)
0 diff
(100 %id)
EC521472 Prostate SAR1AandTYSND1andAIFM2.k 2029 to 2136 106 to 3       104/106
(98 %)
0 diff
(100 %id)
EC521719 Prostate SAR1AandTYSND1andAIFM2.k 2029 to 2136 106 to 3       104/106
(98 %)
0 diff
(100 %id)
NM_020150.4   SAR1AandTYSND1andAIFM2.l 1 to 2993 2 to 2994 exact RefSeq, AAA   2994/2994
(100 %)
0 diff
(100 %id)
DA341205 substantia nigra SAR1AandTYSND1andAIFM2.l 8 to 586 2 to 580   tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DA124038 cerebellum SAR1AandTYSND1andAIFM2.l 9 to 561 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA309566 hippocampus SAR1AandTYSND1andAIFM2.l 9 to 612 2 to 605   capped   604/604
(100 %)
3 diff
(99.6 %id)
DA550573   SAR1AandTYSND1andAIFM2.l 9 to 505 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
BI559720 testis SAR1AandTYSND1andAIFM2.l 10 to 829 1 to 824 exact     824/824
(100 %)
16 diff
(98.1 %id)
DA018774   SAR1AandTYSND1andAIFM2.l 11 to 674 2 to 666   capped   665/665
(100 %)
6 diff
(99.1 %id)
DA108258 cerebellum SAR1AandTYSND1andAIFM2.l 11 to 588 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA511044 brain SAR1AandTYSND1andAIFM2.l 11 to 591 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BG701271 brain, hippocampus SAR1AandTYSND1andAIFM2.l 12 to 768 1 to 756 K160Q     756/758
(99 %)
7 diff
(99.1 %id)
TI_44347980   SAR1AandTYSND1andAIFM2.l 15 to 829 92 to 910 exact     819/910
(90 %)
17 diff
(98.2 %id)
BP288912 lung SAR1AandTYSND1andAIFM2.l 15 to 598 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA025309   SAR1AandTYSND1andAIFM2.l 16 to 572 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AY008268 lung SAR1AandTYSND1andAIFM2.l 16 to 2993 8 to 2978 exact tiling clone, AAA   2971/2978
(99 %)
14 diff
(99.6 %id)
DA159332 amygdala SAR1AandTYSND1andAIFM2.l 16 to 592 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DA172564 amygdala SAR1AandTYSND1andAIFM2.l 16 to 588 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA281149 corpus callosum SAR1AandTYSND1andAIFM2.l 16 to 580 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA295169 hippocampus SAR1AandTYSND1andAIFM2.l 16 to 603 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA345979 substantia nigra SAR1AandTYSND1andAIFM2.l 16 to 604 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DA353052 substantia nigra SAR1AandTYSND1andAIFM2.l 16 to 566 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BU661463 blood SAR1AandTYSND1andAIFM2.l 16 to 712 1 to 697       697/697
(100 %)
4 diff
(99.5 %id)
DA500373 brain SAR1AandTYSND1andAIFM2.l 16 to 601 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA813791   SAR1AandTYSND1andAIFM2.l 16 to 580 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA815656   SAR1AandTYSND1andAIFM2.l 16 to 585 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA993309 synovial membrane tissue from rheumatioidarthritis SAR1AandTYSND1andAIFM2.l 16 to 552 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB031009 testis SAR1AandTYSND1andAIFM2.l 16 to 405 2 to 391   capped   390/392
(99 %)
1 diff
(99.8 %id)
DB161382 thymus SAR1AandTYSND1andAIFM2.l 16 to 594 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB167489 kidney, tumor tissue SAR1AandTYSND1andAIFM2.l 16 to 577 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AL136724 Kidney SAR1AandTYSND1andAIFM2.l 17 to 2984 1 to 2969 exact tiling clone, available from DKFZ, AAA   2969/2969
(100 %)
16 diff
(99.5 %id)
BP315559 mammary gland SAR1AandTYSND1andAIFM2.l 17 to 597 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA030735   SAR1AandTYSND1andAIFM2.l 18 to 577 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA290843 hippocampus SAR1AandTYSND1andAIFM2.l 18 to 588 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA554080   SAR1AandTYSND1andAIFM2.l 18 to 566 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA722262   SAR1AandTYSND1andAIFM2.l 18 to 595 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA821060 pericardium SAR1AandTYSND1andAIFM2.l 18 to 586 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA990373 synovial membrane tissue from rheumatioidarthritis SAR1AandTYSND1andAIFM2.l 18 to 549 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DB138525 thymus SAR1AandTYSND1andAIFM2.l 18 to 550 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB151279 thymus SAR1AandTYSND1andAIFM2.l 18 to 584 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB267213 uterus SAR1AandTYSND1andAIFM2.l 18 to 560 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA308081 hippocampus SAR1AandTYSND1andAIFM2.l 20 to 591 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA440490 tongue, tumor tissue SAR1AandTYSND1andAIFM2.l 20 to 613 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
BI668319 brain, hypothalamus SAR1AandTYSND1andAIFM2.l 21 to 829 1 to 812 W86G N88I Y89I L90S P91Q ...     812/813
(99 %)
26 diff
(96.9 %id)
DA574851   SAR1AandTYSND1andAIFM2.l 23 to 576 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA203328 brain SAR1AandTYSND1andAIFM2.l 24 to 601 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BP225512   SAR1AandTYSND1andAIFM2.l 26 to 606 1 to 581       581/581
(100 %)
0 diff
(100 %id)
DA528684 brain SAR1AandTYSND1andAIFM2.l 26 to 629 14 to 617   capped   604/604
(100 %)
0 diff
(100 %id)
BP235400 coronary artery SAR1AandTYSND1andAIFM2.l 26 to 607 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG425412 Kidney, renal cell adenocarcinoma SAR1AandTYSND1andAIFM2.l 26 to 773 1 to 743 L33W D34I N35M A36Q G37A ...     743/928
(80 %)
17 diff
(98.2 %id)
TI_44346286   SAR1AandTYSND1andAIFM2.l 26 to 829 88 to 894 W86G N88I Y89I L90S P91Q ...     807/895
(90 %)
28 diff
(96.9 %id)
DA142963 alzheimer cortex SAR1AandTYSND1andAIFM2.l 27 to 609 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA471136   SAR1AandTYSND1andAIFM2.l 27 to 595 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA491035 brain SAR1AandTYSND1andAIFM2.l 27 to 597 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA510249 brain SAR1AandTYSND1andAIFM2.l 27 to 581 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA773753 brain SAR1AandTYSND1andAIFM2.l 27 to 601 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA792606 brain SAR1AandTYSND1andAIFM2.l 27 to 575 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA858611 placenta SAR1AandTYSND1andAIFM2.l 27 to 619 2 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DA994055 synovial membrane tissue from rheumatioidarthritis SAR1AandTYSND1andAIFM2.l 27 to 572 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DB136193 thymus SAR1AandTYSND1andAIFM2.l 27 to 574 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB136198 thymus SAR1AandTYSND1andAIFM2.l 27 to 568 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
TI_44165376   SAR1AandTYSND1andAIFM2.l 28 to 740 112 to 834 D75G K87*     723/1173
(61 %)
20 diff
(98.3 %id)
BM553762 duodenal adenocarcinoma, cell line, small intestine SAR1AandTYSND1andAIFM2.l 29 to 973 1 to 971 R183S Q184K G185V Y186T G187A ...     971/1072
(90 %)
43 diff
(96.0 %id)
AF087897   SAR1AandTYSND1andAIFM2.l 32 to 1144 1 to 1111 E149V     1111/1113
(99 %)
8 diff
(99.3 %id)
AF217959   SAR1AandTYSND1andAIFM2.l 32 to 1144 1 to 1111 E149V     1111/1113
(99 %)
9 diff
(99.2 %id)
AF261717   SAR1AandTYSND1andAIFM2.l 32 to 777 1 to 745 exact AAA   745/745
(100 %)
1 diff
(99.9 %id)
N23581 melanocyte SAR1AandTYSND1andAIFM2.l 32 to 533 1 to 502       502/504
(99 %)
3 diff
(99.5 %id)
CX761274 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SAR1AandTYSND1andAIFM2.l 32 to 740 39 to 747 exact   Submitted on the opposite strand 709/747
(94 %)
7 diff
(99.1 %id)
AF274026   SAR1AandTYSND1andAIFM2.l 33 to 1144 1 to 1110 E149V     1110/1112
(99 %)
9 diff
(99.2 %id)
BC003658 Skin, melanotic melanoma. SAR1AandTYSND1andAIFM2.l 35 to 1090 1 to 1056 exact available from MGC, AAA   1056/1056
(100 %)
0 diff
(100 %id)
DA343393 substantia nigra SAR1AandTYSND1andAIFM2.l 35 to 626 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
AA354348   SAR1AandTYSND1andAIFM2.l 36 to 333 1 to 298       298/298
(100 %)
0 diff
(100 %id)
CN337777 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SAR1AandTYSND1andAIFM2.l 37 to 690 9 to 662       654/662
(98 %)
7 diff
(99.0 %id)
BI195202 brain, neuroblastoma SAR1AandTYSND1andAIFM2.l 39 to 629 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
DA676731   SAR1AandTYSND1andAIFM2.l 39 to 626 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DN989672 brain, whole brain SAR1AandTYSND1andAIFM2.l 40 to 736 32 to 728 K166X     697/728
(95 %)
10 diff
(98.7 %id)
CV575906 cornea, eye SAR1AandTYSND1andAIFM2.l 42 to 643 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
DA473217   SAR1AandTYSND1andAIFM2.l 43 to 615 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA268337 caudate nucleus SAR1AandTYSND1andAIFM2.l 44 to 583 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB099974 testis SAR1AandTYSND1andAIFM2.l 44 to 622 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
AK312469 hippocampus SAR1AandTYSND1andAIFM2.l 45 to 729 1 to 685 E145G     685/685
(100 %)
1 diff
(99.9 %id)
BM727124 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SAR1AandTYSND1andAIFM2.l 45 to 407 1 to 363   fully sequenced,   363/363
(100 %)
1 diff
(99.8 %id)
DA209612 brain SAR1AandTYSND1andAIFM2.l 46 to 575 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
AA334525   SAR1AandTYSND1andAIFM2.l 48 to 357 1 to 310       310/310
(100 %)
0 diff
(100 %id)
CD676038 eye, lens SAR1AandTYSND1andAIFM2.l 49 to 667 1 to 619       619/619
(100 %)
0 diff
(100 %id)
TI_149285458   SAR1AandTYSND1andAIFM2.l 54 to 763 802 to 93 F5X AAA   710/1176
(60 %)
1 diff
(100.0 %id)
BF800643 colon_ins SAR1AandTYSND1andAIFM2.l 57 to 373 324 to 6     Submitted on the opposite strand 319/428
(74 %)
1 diff
(99.8 %id)
BJ995851 hepatoblastoma SAR1AandTYSND1andAIFM2.l 57 to 511 1 to 455   fully sequenced,   455/455
(100 %)
0 diff
(100 %id)
DA176202 amygdala SAR1AandTYSND1andAIFM2.l 58 to 560 2 to 504   capped   503/503
(100 %)
0 diff
(100 %id)
DA303976 hippocampus SAR1AandTYSND1andAIFM2.l 58 to 605 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA305939 hippocampus SAR1AandTYSND1andAIFM2.l 58 to 653 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
DA342732 substantia nigra SAR1AandTYSND1andAIFM2.l 58 to 635 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA357119 subthalamic nucleus SAR1AandTYSND1andAIFM2.l 58 to 600 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA475011   SAR1AandTYSND1andAIFM2.l 58 to 602 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA479245   SAR1AandTYSND1andAIFM2.l 58 to 613 2 to 557   capped   556/564
(98 %)
1 diff
(99.9 %id)
DA497377 brain SAR1AandTYSND1andAIFM2.l 58 to 619 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA503786 brain SAR1AandTYSND1andAIFM2.l 58 to 605 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA578608   SAR1AandTYSND1andAIFM2.l 58 to 601 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA598290   SAR1AandTYSND1andAIFM2.l 58 to 608 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA600774   SAR1AandTYSND1andAIFM2.l 58 to 619 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA656373   SAR1AandTYSND1andAIFM2.l 58 to 627 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA658164   SAR1AandTYSND1andAIFM2.l 58 to 619 8 to 569   capped   562/562
(100 %)
0 diff
(100 %id)
DA659714   SAR1AandTYSND1andAIFM2.l 58 to 611 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA659964   SAR1AandTYSND1andAIFM2.l 58 to 613 2 to 557   capped   556/564
(98 %)
1 diff
(99.9 %id)
DA709352   SAR1AandTYSND1andAIFM2.l 58 to 622 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA717242   SAR1AandTYSND1andAIFM2.l 58 to 595 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA782227 brain SAR1AandTYSND1andAIFM2.l 58 to 625 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA793295 brain SAR1AandTYSND1andAIFM2.l 58 to 564 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
DA856027 placenta SAR1AandTYSND1andAIFM2.l 58 to 615 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB192166 ovary, tumor tissue SAR1AandTYSND1andAIFM2.l 58 to 611 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BE899481 adenocarcinoma cell line, ovary SAR1AandTYSND1andAIFM2.l 60 to 777 1 to 711 A170V R171A P172H M173G E174S ... AAA   711/711
(100 %)
15 diff
(97.9 %id)
X90540 eye SAR1AandTYSND1andAIFM2.l 64 to 577 514 to 1       514/520
(98 %)
8 diff
(98.5 %id)
AW406969 lymph SAR1AandTYSND1andAIFM2.l 66 to 359 1 to 294       294/294
(100 %)
5 diff
(98.3 %id)
CN337772 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SAR1AandTYSND1andAIFM2.l 69 to 812 1 to 743 exact     743/743
(100 %)
1 diff
(99.9 %id)
BU624092 cell lines, Enchondroma SAR1AandTYSND1andAIFM2.l 70 to 764 713 to 19 exact AAA   695/697
(99 %)
0 diff
(100 %id)
BU507187 leiomyosarcoma, uterus SAR1AandTYSND1andAIFM2.l 77 to 950 12 to 889 exact     878/933
(94 %)
19 diff
(98.0 %id)
CD656028 Embryonic Stem cells SAR1AandTYSND1andAIFM2.l 81 to 880 12 to 803 exact     792/824
(96 %)
19 diff
(97.7 %id)
BM714357 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SAR1AandTYSND1andAIFM2.l 87 to 511 1 to 425   fully sequenced,   425/425
(100 %)
0 diff
(100 %id)
CN337771 embryonic stem cells, DMSO-treated H9 cellline SAR1AandTYSND1andAIFM2.l 88 to 632 1 to 545       545/545
(100 %)
0 diff
(100 %id)
DA181255 amygdala SAR1AandTYSND1andAIFM2.l 89 to 654 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DB098442 testis SAR1AandTYSND1andAIFM2.l 92 to 670 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BM984879 lung SAR1AandTYSND1andAIFM2.l 110 to 763 672 to 19 F5X AAA   654/654
(100 %)
0 diff
(100 %id)
BU740968 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SAR1AandTYSND1andAIFM2.l 346 to 777 449 to 19   fully sequenced, AAA   431/431
(100 %)
1 diff
(99.8 %id)
AW575418 lymph SAR1AandTYSND1andAIFM2.l 417 to 767 368 to 18   AAA   351/351
(100 %)
0 diff
(100 %id)
BJ995852 hepatoblastoma SAR1AandTYSND1andAIFM2.l 450 to 739 290 to 1   fully sequenced,   290/290
(100 %)
0 diff
(100 %id)
BM675161 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid SAR1AandTYSND1andAIFM2.l 450 to 764 333 to 19   fully sequenced, AAA   315/315
(100 %)
0 diff
(100 %id)
AK074257   SAR1AandTYSND1andAIFM2.l 1524 to 3635 1 to 2106   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2106/2106
(100 %)
17 diff
(99.2 %id)
TI_154194106   SAR1AandTYSND1andAIFM2.l 2099 to 3001 51 to 947       897/1030
(87 %)
37 diff
(96.5 %id)
BU568981 testis SAR1AandTYSND1andAIFM2.l 2183 to 2866 1 to 694       694/800
(86 %)
23 diff
(97.2 %id)
BM698687 eye, fetal eyes SAR1AandTYSND1andAIFM2.l 2193 to 2462 1 to 270   fully sequenced,   270/270
(100 %)
2 diff
(99.3 %id)
AV705720 adrenal gland SAR1AandTYSND1andAIFM2.l 2208 to 2929 1 to 719       719/719
(100 %)
5 diff
(99.4 %id)
BQ954254 sciatic nerve SAR1AandTYSND1andAIFM2.l 2214 to 2998 1 to 786   AAA   786/786
(100 %)
1 diff
(99.9 %id)
AW801917 uterus SAR1AandTYSND1andAIFM2.l 2229 to 2574 361 to 16       346/361
(95 %)
0 diff
(100 %id)
BX281349 melanotic melanoma, skin SAR1AandTYSND1andAIFM2.l 2244 to 2738 1 to 495       495/495
(100 %)
0 diff
(100 %id)
BM453963 melanotic melanoma, skin SAR1AandTYSND1andAIFM2.l 2244 to 2998 1 to 755   tiling clone, AAA   755/755
(100 %)
0 diff
(100 %id)
TI_149273528   SAR1AandTYSND1andAIFM2.l 2257 to 3001 865 to 128       738/1083
(68 %)
0 diff
(100 %id)
TI_149315659   SAR1AandTYSND1andAIFM2.l 2263 to 2998 809 to 82   AAA   728/937
(77 %)
13 diff
(98.7 %id)
BM845092 lymph node, stomach SAR1AandTYSND1andAIFM2.l 2276 to 2856 585 to 4     Submitted on the opposite strand 582/585
(99 %)
0 diff
(100 %id)
CF130749 Chondrosarcoma Lung Metastasis cell lines, lung SAR1AandTYSND1andAIFM2.l 2279 to 2985 1 to 708       708/708
(100 %)
8 diff
(98.9 %id)
EB362337 eye, lens SAR1AandTYSND1andAIFM2.l 2296 to 2998 703 to 1       703/703
(100 %)
1 diff
(99.9 %id)
CA447918 Chondrosarcoma, Left Pelvis SAR1AandTYSND1andAIFM2.l 2303 to 2998 709 to 14   AAA   696/696
(100 %)
0 diff
(100 %id)
CA436844 Bone, Subchondral Bone SAR1AandTYSND1andAIFM2.l 2324 to 2998 694 to 19   AAA   676/678
(99 %)
3 diff
(99.6 %id)
BI223562 cervical carcinoma cell line, cervix SAR1AandTYSND1andAIFM2.l 2325 to 3001 1 to 682       682/724
(94 %)
14 diff
(98.1 %id)
BQ008447 Chondrosarcoma, Left Pubic Bone SAR1AandTYSND1andAIFM2.l 2325 to 2998 686 to 14   AAA   673/673
(100 %)
2 diff
(99.8 %id)
CB250461 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.l 2336 to 2998 676 to 14   AAA   663/663
(100 %)
3 diff
(99.6 %id)
BM760609 lymph node, stomach SAR1AandTYSND1andAIFM2.l 2339 to 2860 523 to 1     Submitted on the opposite strand 523/523
(100 %)
1 diff
(99.9 %id)
BM670758 eye, fetal eyes SAR1AandTYSND1andAIFM2.l 2342 to 2998 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
BG106714 lymph, lymphoma, cell line SAR1AandTYSND1andAIFM2.l 2345 to 2997 657 to 1     Submitted on the opposite strand 657/969
(67 %)
11 diff
(98.9 %id)
CN336615 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 SAR1AandTYSND1andAIFM2.l 2360 to 2982 1 to 623       623/623
(100 %)
0 diff
(100 %id)
N79652 multiple sclerosis lesions SAR1AandTYSND1andAIFM2.l 2373 to 2570 1 to 198       198/198
(100 %)
0 diff
(100 %id)
N77775 multiple sclerosis lesions SAR1AandTYSND1andAIFM2.l 2373 to 2708 1 to 340   fully sequenced,   340/340
(100 %)
1 diff
(99.8 %id)
BU072468 Pancreas, Purified pancreatic islet SAR1AandTYSND1andAIFM2.l 2386 to 2998 613 to 1       613/613
(100 %)
0 diff
(100 %id)
CB306447 lung, Primary Lung Cystic Fibrosis EpithelialCells SAR1AandTYSND1andAIFM2.l 2401 to 2998 611 to 14   AAA   598/598
(100 %)
1 diff
(99.9 %id)
CA312018 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.l 2401 to 2998 611 to 14   AAA   598/616
(97 %)
2 diff
(99.7 %id)
CA312038 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.l 2401 to 2998 611 to 14   AAA   598/607
(98 %)
2 diff
(99.7 %id)
CB858015 anterior tongue, pooled SAR1AandTYSND1andAIFM2.l 2411 to 2612 202 to 1     Submitted on the opposite strand 202/202
(100 %)
13 diff
(93.6 %id)
BE855644 brain, glioblastoma (pooled) SAR1AandTYSND1andAIFM2.l 2413 to 2993 581 to 1       581/581
(100 %)
0 diff
(100 %id)
BM670777 eye, fetal eyes SAR1AandTYSND1andAIFM2.l 2432 to 2993 580 to 19   fully sequenced, AAA   562/562
(100 %)
0 diff
(100 %id)
AK025857   SAR1AandTYSND1andAIFM2.l 2434 to 2993 1 to 560   available from FLJ, AAA   560/560
(100 %)
3 diff
(99.5 %id)
BM700774 eye, human retina SAR1AandTYSND1andAIFM2.l 2439 to 2981 9 to 549   fully sequenced,   541/549
(98 %)
6 diff
(99.0 %id)
FN160706 breast carcinoma SAR1AandTYSND1andAIFM2.l 2444 to 2566 120 to 1     Submitted on the opposite strand 120/120
(100 %)
5 diff
(95.9 %id)
DB303519 amygdala SAR1AandTYSND1andAIFM2.l 2445 to 2985 542 to 1       542/542
(100 %)
2 diff
(99.7 %id)
W68801 heart SAR1AandTYSND1andAIFM2.l 2447 to 2626 1 to 181   fully sequenced,   181/181
(100 %)
1 diff
(99.5 %id)
BM845989 lymph node, stomach SAR1AandTYSND1andAIFM2.l 2447 to 2860 415 to 1     Submitted on the opposite strand 415/415
(100 %)
1 diff
(99.8 %id)
DB349503 trachea SAR1AandTYSND1andAIFM2.l 2452 to 2998 548 to 1       548/548
(100 %)
4 diff
(99.3 %id)
W07436 lung SAR1AandTYSND1andAIFM2.l 2473 to 2999 1 to 528   fully sequenced,   528/528
(100 %)
12 diff
(97.8 %id)
BQ102359 Islets of Langerhans, Pancreas SAR1AandTYSND1andAIFM2.l 2494 to 3000 507 to 1       507/507
(100 %)
0 diff
(100 %id)
AW069048 bone marrow stroma SAR1AandTYSND1andAIFM2.l 2530 to 2998 487 to 19   AAA   469/469
(100 %)
0 diff
(100 %id)
AA301377 testis SAR1AandTYSND1andAIFM2.l 2541 to 2812 1 to 272       272/272
(100 %)
0 diff
(100 %id)
AI624380 adenocarcinoma, Pancreas SAR1AandTYSND1andAIFM2.l 2546 to 3001 456 to 1       456/456
(100 %)
0 diff
(100 %id)
AI086814 senescent fibroblast SAR1AandTYSND1andAIFM2.l 2560 to 2998 449 to 11   AAA   439/439
(100 %)
0 diff
(100 %id)
AI086819 senescent fibroblast SAR1AandTYSND1andAIFM2.l 2561 to 2998 448 to 11   AAA   438/438
(100 %)
0 diff
(100 %id)
AI868032 uterus SAR1AandTYSND1andAIFM2.l 2562 to 2993 432 to 1       432/432
(100 %)
0 diff
(100 %id)
H98858 melanocyte SAR1AandTYSND1andAIFM2.l 2569 to 2991 431 to 8       424/432
(98 %)
0 diff
(100 %id)
DB548316 hippocampus SAR1AandTYSND1andAIFM2.l 2570 to 2998 1 to 429     Submitted on the opposite strand 429/429
(100 %)
0 diff
(100 %id)
AA972874 colon, colon tumor SAR1AandTYSND1andAIFM2.l 2572 to 2998 427 to 1       427/427
(100 %)
0 diff
(100 %id)
AW152119 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SAR1AandTYSND1andAIFM2.l 2581 to 2998 418 to 1       418/418
(100 %)
0 diff
(100 %id)
AW872907 squamous cell carcinoma, tongue SAR1AandTYSND1andAIFM2.l 2586 to 3000 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AI769249 pooled SAR1AandTYSND1andAIFM2.l 2591 to 2998 418 to 11   AAA   408/408
(100 %)
0 diff
(100 %id)
W68604 heart SAR1AandTYSND1andAIFM2.l 2596 to 2998 405 to 1   fully sequenced,   405/405
(100 %)
4 diff
(99.1 %id)
AI470172 pooled SAR1AandTYSND1andAIFM2.l 2597 to 2998 412 to 11   AAA   402/402
(100 %)
0 diff
(100 %id)
AW128933 brain, tumor, 5 pooled (see description) SAR1AandTYSND1andAIFM2.l 2597 to 2998 421 to 20   AAA   402/402
(100 %)
0 diff
(100 %id)
AA972543 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.l 2612 to 2998 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA248544   SAR1AandTYSND1andAIFM2.l 2617 to 2833 215 to 1     Submitted on the opposite strand 215/217
(99 %)
4 diff
(98.2 %id)
AA886239 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.l 2622 to 2989 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AA769518 germinal center B cell SAR1AandTYSND1andAIFM2.l 2626 to 2998 405 to 33   AAA   373/373
(100 %)
0 diff
(100 %id)
TI_154088986   SAR1AandTYSND1andAIFM2.l 2627 to 3001 78 to 448     Submitted on the opposite strand 371/655
(56 %)
9 diff
(98.7 %id)
BM855318 stomach SAR1AandTYSND1andAIFM2.l 2629 to 2796 1 to 168       168/168
(100 %)
0 diff
(100 %id)
N63975 multiple sclerosis lesions SAR1AandTYSND1andAIFM2.l 2633 to 2998 367 to 1       367/367
(100 %)
3 diff
(99.2 %id)
CB242067 Human Lung Epithelial cells, lung SAR1AandTYSND1andAIFM2.l 2633 to 2996 1 to 369     Submitted on the opposite strand 369/378
(97 %)
8 diff
(97.9 %id)
AW007561 colon SAR1AandTYSND1andAIFM2.l 2643 to 2991 1 to 349     Submitted on the opposite strand 349/349
(100 %)
0 diff
(100 %id)
AA507994 Prostate SAR1AandTYSND1andAIFM2.l 2669 to 2993 349 to 25   AAA   325/325
(100 %)
1 diff
(99.7 %id)
AI697619 carcinoid, lung SAR1AandTYSND1andAIFM2.l 2670 to 2997 328 to 1       328/328
(100 %)
0 diff
(100 %id)
N62869 multiple sclerosis lesions SAR1AandTYSND1andAIFM2.l 2678 to 2995 319 to 1   fully sequenced,   319/319
(100 %)
2 diff
(99.4 %id)
AA303167 aorta SAR1AandTYSND1andAIFM2.l 2683 to 3001 319 to 3     Submitted on the opposite strand 317/319
(99 %)
0 diff
(100 %id)
Z28956 leg muscle, skeletal muscle SAR1AandTYSND1andAIFM2.l 2698 to 2865 174 to 1       174/181
(96 %)
7 diff
(96.2 %id)
W60913 heart SAR1AandTYSND1andAIFM2.l 2713 to 2998 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AI580727 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SAR1AandTYSND1andAIFM2.l 2739 to 3000 262 to 1       262/262
(100 %)
0 diff
(100 %id)
AI474545 Prostate SAR1AandTYSND1andAIFM2.l 2740 to 3000 261 to 1       261/261
(100 %)
0 diff
(100 %id)
FN135515 breast carcinoma SAR1AandTYSND1andAIFM2.l 2768 to 2862 95 to 1     Submitted on the opposite strand 95/95
(100 %)
4 diff
(95.8 %id)
AW382222 head_neck SAR1AandTYSND1andAIFM2.l 2778 to 3115 355 to 21   tiling clone,   335/365
(91 %)
0 diff
(100 %id)
AI470275 poorly differentiated adenocarcinoma withsignet ring cell features, stomach SAR1AandTYSND1andAIFM2.l 2791 to 2993 220 to 18   AAA   203/203
(100 %)
0 diff
(100 %id)
FN081068 breast carcinoma SAR1AandTYSND1andAIFM2.l 2844 to 2940 97 to 1     Submitted on the opposite strand 97/101
(96 %)
0 diff
(100 %id)
D20438   SAR1AandTYSND1andAIFM2.l 2848 to 3001 1 to 154     Submitted on the opposite strand 154/154
(100 %)
0 diff
(100 %id)
BM672153 eye, human retina SAR1AandTYSND1andAIFM2.l 2877 to 2993 133 to 19   fully sequenced, AAA   115/115
(100 %)
1 diff
(99.2 %id)
N75852 lung SAR1AandTYSND1andAIFM2.l 2914 to 2998 85 to 1   fully sequenced,   85/85
(100 %)
0 diff
(100 %id)
BF366693 nervous_tumor SAR1AandTYSND1andAIFM2.l 3145 to 3351 208 to 1   tiling clone,   208/212
(98 %)
7 diff
(96.7 %id)
BQ346824 nervous_tumor SAR1AandTYSND1andAIFM2.l 3152 to 3351 192 to 1       192/219
(87 %)
13 diff
(94.1 %id)
AI301305 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.l 3226 to 3646 421 to 1   tiling clone,   421/421
(100 %)
1 diff
(99.8 %id)
CV805418 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SAR1AandTYSND1andAIFM2.m 1 to 830 1 to 837 D170N Q183A R184X L186P A187G ... tiling clone,   837/891
(93 %)
22 diff
(97.6 %id)
CV806489 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass SAR1AandTYSND1andAIFM2.m 1 to 851 1 to 855 E188K tiling clone,   855/879
(97 %)
20 diff
(97.8 %id)
AK298591   SAR1AandTYSND1andAIFM2.n 1 to 1078 5 to 1082 exact tiling clone,   1082/1082
(100 %)
0 diff
(100 %id)
DC364620   SAR1AandTYSND1andAIFM2.n 1 to 459 5 to 463       463/463
(100 %)
0 diff
(100 %id)
CD634367   SAR1AandTYSND1andAIFM2.o 1 to 655 8 to 662   tiling clone,   655/662
(98 %)
6 diff
(99.1 %id)
CD634368   SAR1AandTYSND1andAIFM2.o 1 to 682 697 to 17 exact tiling clone,   681/725
(93 %)
1 diff
(99.9 %id)
DA739481   SAR1AandTYSND1andAIFM2.p 1 to 519 2 to 520   tiling clone, capped   519/519
(100 %)
0 diff
(100 %id)
FN153813 breast carcinoma SAR1AandTYSND1andAIFM2.p 93 to 167 1 to 75       75/76
(98 %)
1 diff
(98.7 %id)
BF434139 fibrotheoma, ovary SAR1AandTYSND1andAIFM2.p 106 to 599 498 to 5   tiling clone,   494/498
(99 %)
0 diff
(100 %id)
N35871 melanocyte SAR1AandTYSND1andAIFM2.p 113 to 391 1 to 278       278/281
(98 %)
2 diff
(99.3 %id)
BG900135 cartilage SAR1AandTYSND1andAIFM2.p 134 to 489 79 to 434       356/366
(97 %)
8 diff
(97.9 %id)
DW439464 Liver SAR1AandTYSND1andAIFM2.p 290 to 515 17 to 242       226/242
(93 %)
7 diff
(97.2 %id)
BP336751 coronary artery SAR1AandTYSND1andAIFM2.q 1 to 592 6 to 597 N162S tiling clone,   597/597
(100 %)
3 diff
(99.5 %id)
BP353283   SAR1AandTYSND1andAIFM2.r 1 to 578 5 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BX490168   SAR1AandTYSND1andAIFM2.s 1 to 542 1 to 542   tiling clone,   542/542
(100 %)
1 diff
(99.9 %id)
DA775210 brain SAR1AandTYSND1andAIFM2.s 45 to 612 2 to 569 S145G tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
DB287983 uterus SAR1AandTYSND1andAIFM2.t 1 to 557 2 to 562 exact tiling clone, capped   561/561
(100 %)
4 diff
(99.3 %id)
BU528912 epidermoid carcinoma, cell line, lung SAR1AandTYSND1andAIFM2.u 1 to 752 1 to 755 K123N tiling clone,   755/895
(84 %)
9 diff
(99.0 %id)
DA298114 hippocampus SAR1AandTYSND1andAIFM2.u 24 to 587 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DA533378 brain SAR1AandTYSND1andAIFM2.va 1 to 495 2 to 496 exact tiling clone, capped   495/496
(99 %)
2 diff
(99.6 %id)
DA727193   SAR1AandTYSND1andAIFM2.vb 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA804945 brain SAR1AandTYSND1andAIFM2.vc 1 to 545 7 to 550 S124A Q125S Q126R A127P A128L ... tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
DB211805 trachea SAR1AandTYSND1andAIFM2.vd 1 to 358 2 to 359   tiling clone, capped   358/358
(100 %)
0 diff
(100 %id)
DA028731   SAR1AandTYSND1andAIFM2.vd 3 to 571 2 to 571 R15X R16S V17R W18L K19E ... tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
CD702967 normal nasopharynx SAR1AandTYSND1andAIFM2.ve 1 to 469 26 to 494   tiling clone,   469/494
(94 %)
7 diff
(98.6 %id)
AA290688 germinal center B cell SAR1AandTYSND1andAIFM2.ve 151 to 571 1 to 421   tiling clone,   421/421
(100 %)
0 diff
(100 %id)
TI_57176478   SAR1AandTYSND1andAIFM2.vf 1 to 884 55 to 939 exact tiling clone,   885/940
(94 %)
27 diff
(97.2 %id)
BI829894 brain, medulla SAR1AandTYSND1andAIFM2.vf 10 to 503 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BG204563   SAR1AandTYSND1andAIFM2.vf 93 to 896 1 to 796 Y62H tiling clone,   796/802
(99 %)
25 diff
(96.9 %id)
AI582885 adenocarcinoma, Pancreas SAR1AandTYSND1andAIFM2.vg 1 to 662 678 to 16 Q5R I6S P13Q L15* tiling clone, AAA   663/670
(98 %)
8 diff
(98.9 %id)
CF121920 lymph SAR1AandTYSND1andAIFM2.vh-u 1 to 241 8 to 249   tiling clone,   242/249
(97 %)
6 diff
(97.6 %id)
DB222692 trachea SAR1AandTYSND1andAIFM2.vh-u 175 to 718 2 to 546   tiling clone, capped   545/545
(100 %)
3 diff
(99.5 %id)
BE061662 breast SAR1AandTYSND1andAIFM2.vh-u 284 to 530 4 to 250       247/250
(98 %)
6 diff
(97.6 %id)
DA652945   SAR1AandTYSND1andAIFM2.vi 1 to 540 2 to 542 exact tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
CN337776 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.vj 1 to 579 4 to 582 exact tiling clone,   582/582
(100 %)
0 diff
(100 %id)
CD671353 eye, Iris SAR1AandTYSND1andAIFM2.vk 1 to 599 3 to 601 exact tiling clone,   601/601
(100 %)
0 diff
(100 %id)
AW511084 pooled SAR1AandTYSND1andAIFM2.vk 205 to 740 529 to 1   tiling clone,   529/595
(88 %)
18 diff
(97.0 %id)
BX649035 human retina SAR1AandTYSND1andAIFM2.vl-u 1 to 3290 3290 to 1 E65G tiling clone, available from DKFZ, Submitted on the opposite strand 3290/3290
(100 %)
4 diff
(99.9 %id)
DB023622 testis SAR1AandTYSND1andAIFM2.vl-u 2316 to 2869 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BI832057 brain, medulla SAR1AandTYSND1andAIFM2.vl-u 2383 to 3025 1 to 660       660/660
(100 %)
29 diff
(95.7 %id)
TI_57173047   SAR1AandTYSND1andAIFM2.vl-u 2383 to 3025 1 to 660       660/660
(100 %)
29 diff
(95.7 %id)
F06188 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 1 to 299 1 to 299       299/299
(100 %)
0 diff
(100 %id)
H18580 whole brain SAR1AandTYSND1andAIFM2.vm-u 1 to 439 1 to 444   tiling clone, Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 444/485
(91 %)
11 diff
(97.8 %id)
F06686 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 2 to 329 1 to 328       328/328
(100 %)
1 diff
(99.7 %id)
R53666 whole brain SAR1AandTYSND1andAIFM2.vm-u 2 to 371 1 to 372     Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 372/409
(90 %)
5 diff
(98.8 %id)
BY994612   SAR1AandTYSND1andAIFM2.vm-u 479 to 1156 18 to 695 exact tiling clone,   678/695
(97 %)
6 diff
(99.2 %id)
CV373241 lung_tumor SAR1AandTYSND1andAIFM2.vm-u 523 to 813 1 to 298       298/298
(100 %)
29 diff
(90.3 %id)
CU446989 epidermis SAR1AandTYSND1andAIFM2.vm-u 525 to 1061 1 to 537 exact     537/537
(100 %)
8 diff
(98.6 %id)
CU449577 epidermis SAR1AandTYSND1andAIFM2.vm-u 525 to 1064 1 to 540 exact tiling clone,   540/553
(97 %)
8 diff
(98.6 %id)
BI017743 lung_tumor SAR1AandTYSND1andAIFM2.vm-u 539 to 945 59 to 478       420/478
(87 %)
6 diff
(98.8 %id)
BQ331376 lung_tumor SAR1AandTYSND1andAIFM2.vm-u 539 to 1049 61 to 570 P11A Y40*     510/572
(89 %)
17 diff
(97.1 %id)
BG218813   SAR1AandTYSND1andAIFM2.vm-u 815 to 1521 1 to 701       701/720
(97 %)
27 diff
(96.3 %id)
BG202498   SAR1AandTYSND1andAIFM2.vm-u 832 to 1572 1 to 741       741/742
(99 %)
8 diff
(99.0 %id)
BQ230588 epithelioid carcinoma, Pancreas SAR1AandTYSND1andAIFM2.vm-u 835 to 1606 28 to 819       792/944
(83 %)
31 diff
(96.8 %id)
BI160075 epithelioid carcinoma cell line, Pancreas SAR1AandTYSND1andAIFM2.vm-u 872 to 1672 1 to 806       806/853
(94 %)
7 diff
(99.2 %id)
BI766480 pooled lung and spleen SAR1AandTYSND1andAIFM2.vm-u 900 to 998 1 to 99       99/99
(100 %)
0 diff
(100 %id)
TI_57177645   SAR1AandTYSND1andAIFM2.vm-u 900 to 1729 1 to 826       826/829
(99 %)
5 diff
(99.4 %id)
TI_149296968   SAR1AandTYSND1andAIFM2.vm-u 911 to 1757 924 to 95   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 830/929
(89 %)
21 diff
(97.8 %id)
Z43041 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 966 to 1204 1 to 238       238/238
(100 %)
2 diff
(99.2 %id)
BG683405 brain, neuroblastoma, cell line SAR1AandTYSND1andAIFM2.vm-u 980 to 1690 724 to 4       721/724
(99 %)
0 diff
(100 %id)
BF965861 Bone, osteosarcoma, cell line SAR1AandTYSND1andAIFM2.vm-u 990 to 1688 1 to 702       702/702
(100 %)
3 diff
(99.6 %id)
BM982113 lung, Primary Lung Cystic Fibrosis EpithelialCells SAR1AandTYSND1andAIFM2.vm-u 993 to 1757 777 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 759/761
(99 %)
10 diff
(98.7 %id)
TI_149299621   SAR1AandTYSND1andAIFM2.vm-u 1013 to 1746 813 to 83   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 731/955
(76 %)
7 diff
(99.3 %id)
EC563614 Prostate SAR1AandTYSND1andAIFM2.vm-u 1036 to 1138 99 to 1       99/99
(100 %)
3 diff
(97.0 %id)
BM975929 lung, Primary Lung Cystic Fibrosis EpithelialCells SAR1AandTYSND1andAIFM2.vm-u 1070 to 1746 695 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 677/677
(100 %)
0 diff
(100 %id)
BG255450 adenocarcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.vm-u 1092 to 1738 1 to 646       646/646
(100 %)
5 diff
(99.3 %id)
AL713282 human skeletal muscle SAR1AandTYSND1andAIFM2.vm-u 1102 to 1586 1 to 485       485/485
(100 %)
0 diff
(100 %id)
BG389635 embryonal carcinoma, cell line, testis SAR1AandTYSND1andAIFM2.vm-u 1125 to 1750 1 to 626   AAA   626/633
(98 %)
5 diff
(99.3 %id)
BX393106   SAR1AandTYSND1andAIFM2.vm-u 1131 to 1741 617 to 1       617/736
(83 %)
44 diff
(94.1 %id)
BU599925 mixed (pool of 40 RNAs) SAR1AandTYSND1andAIFM2.vm-u 1135 to 1752 1 to 627       627/673
(93 %)
14 diff
(98.0 %id)
AA355658   SAR1AandTYSND1andAIFM2.vm-u 1147 to 1420 1 to 275       275/275
(100 %)
1 diff
(99.7 %id)
AW962808   SAR1AandTYSND1andAIFM2.vm-u 1148 to 1610 1 to 462       462/462
(100 %)
2 diff
(99.6 %id)
AI382207 B-cell, chronic lymphotic leukemia SAR1AandTYSND1andAIFM2.vm-u 1240 to 1749 510 to 1       510/510
(100 %)
0 diff
(100 %id)
BP396641 pancreatic islet SAR1AandTYSND1andAIFM2.vm-u 1253 to 1751 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
AI453584 pooled SAR1AandTYSND1andAIFM2.vm-u 1255 to 1751 498 to 2       497/498
(99 %)
0 diff
(100 %id)
AI563945 anaplastic oligodendroglioma, brain SAR1AandTYSND1andAIFM2.vm-u 1266 to 1751 490 to 5       486/490
(99 %)
0 diff
(100 %id)
AA620731   SAR1AandTYSND1andAIFM2.vm-u 1268 to 1750 481 to 1       481/481
(100 %)
2 diff
(99.6 %id)
AA805286 germinal center B cell SAR1AandTYSND1andAIFM2.vm-u 1276 to 1764 497 to 13   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 485/485
(100 %)
4 diff
(99.2 %id)
AI762662 B-cell, chronic lymphotic leukemia SAR1AandTYSND1andAIFM2.vm-u 1277 to 1749 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
AW178373 head_neck SAR1AandTYSND1andAIFM2.vm-u 1279 to 1539 261 to 1       261/261
(100 %)
0 diff
(100 %id)
AI092722 parathyroid gland, parathyroid tumor SAR1AandTYSND1andAIFM2.vm-u 1282 to 1751 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AW188353 pooled SAR1AandTYSND1andAIFM2.vm-u 1285 to 1750 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BX118724 whole brain SAR1AandTYSND1andAIFM2.vm-u 1288 to 1744 470 to 15   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 456/456
(100 %)
1 diff
(99.8 %id)
AI377960 pooled SAR1AandTYSND1andAIFM2.vm-u 1290 to 1749 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AW573136 pooled SAR1AandTYSND1andAIFM2.vm-u 1292 to 1759 471 to 4       468/471
(99 %)
0 diff
(100 %id)
AI400316 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SAR1AandTYSND1andAIFM2.vm-u 1295 to 1747 453 to 1       453/457
(99 %)
5 diff
(99.0 %id)
DB517872 testis SAR1AandTYSND1andAIFM2.vm-u 1305 to 1744 1 to 440     Submitted on the opposite strand 440/442
(99 %)
1 diff
(99.8 %id)
AI283465 pooled SAR1AandTYSND1andAIFM2.vm-u 1306 to 1759 455 to 3       453/455
(99 %)
0 diff
(100 %id)
AI040997   SAR1AandTYSND1andAIFM2.vm-u 1308 to 1753 450 to 5       446/450
(99 %)
0 diff
(100 %id)
DB515355 testis SAR1AandTYSND1andAIFM2.vm-u 1318 to 1744 1 to 427     Submitted on the opposite strand 427/429
(99 %)
1 diff
(99.8 %id)
AA641019 invasive tumor (cell line), Prostate SAR1AandTYSND1andAIFM2.vm-u 1319 to 1769 502 to 51   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 452/452
(100 %)
15 diff
(96.7 %id)
AI124040 heart SAR1AandTYSND1andAIFM2.vm-u 1321 to 1747 426 to 1       426/426
(100 %)
3 diff
(99.3 %id)
DB507361 testis SAR1AandTYSND1andAIFM2.vm-u 1328 to 1746 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
AA523440 colon SAR1AandTYSND1andAIFM2.vm-u 1331 to 1746 419 to 1       419/419
(100 %)
6 diff
(98.6 %id)
AI018339 pooled SAR1AandTYSND1andAIFM2.vm-u 1338 to 1751 417 to 4       414/417
(99 %)
0 diff
(100 %id)
AI123942 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SAR1AandTYSND1andAIFM2.vm-u 1338 to 1751 416 to 3       414/416
(99 %)
0 diff
(100 %id)
DB509396 testis SAR1AandTYSND1andAIFM2.vm-u 1341 to 1758 1 to 418     Submitted on the opposite strand 418/418
(100 %)
0 diff
(100 %id)
AW087355 esophagus, squamous cell carcinoma SAR1AandTYSND1andAIFM2.vm-u 1343 to 1755 433 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 414/414
(100 %)
6 diff
(98.6 %id)
BG222310 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification SAR1AandTYSND1andAIFM2.vm-u 1348 to 1748 401 to 1       401/401
(100 %)
4 diff
(99.1 %id)
AI024441   SAR1AandTYSND1andAIFM2.vm-u 1351 to 1753 407 to 5       403/407
(99 %)
0 diff
(100 %id)
H18472 whole brain SAR1AandTYSND1andAIFM2.vm-u 1378 to 1746 393 to 19   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 375/376
(99 %)
6 diff
(98.5 %id)
R53555 whole brain SAR1AandTYSND1andAIFM2.vm-u 1384 to 1746 384 to 17   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 368/372
(98 %)
5 diff
(98.7 %id)
AA769557 germinal center B cell SAR1AandTYSND1andAIFM2.vm-u 1384 to 1751 373 to 5       369/373
(98 %)
0 diff
(100 %id)
T83889 liver and spleen SAR1AandTYSND1andAIFM2.vm-u 1389 to 1746 360 to 1       360/364
(98 %)
9 diff
(97.6 %id)
BF439826 pooled SAR1AandTYSND1andAIFM2.vm-u 1400 to 1751 354 to 3       352/354
(99 %)
0 diff
(100 %id)
AI684935 pooled SAR1AandTYSND1andAIFM2.vm-u 1405 to 1750 346 to 1       346/346
(100 %)
2 diff
(99.5 %id)
AA908983 pooled SAR1AandTYSND1andAIFM2.vm-u 1411 to 1759 352 to 4       349/352
(99 %)
0 diff
(100 %id)
DW419198 Liver SAR1AandTYSND1andAIFM2.vm-u 1414 to 1742 17 to 345   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 329/345
(95 %)
6 diff
(98.3 %id)
AI567840 ovary, tumor, 5 pooled (see description) SAR1AandTYSND1andAIFM2.vm-u 1414 to 1759 347 to 2       346/347
(99 %)
0 diff
(100 %id)
AA953270 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.vm-u 1430 to 1746 317 to 1       317/317
(100 %)
0 diff
(100 %id)
CN298775 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells SAR1AandTYSND1andAIFM2.vm-u 1435 to 2071 1 to 636   tiling clone,   636/636
(100 %)
2 diff
(99.7 %id)
DB518185 testis SAR1AandTYSND1andAIFM2.vm-u 1438 to 1746 1 to 309     Submitted on the opposite strand 309/309
(100 %)
4 diff
(98.8 %id)
BX340786   SAR1AandTYSND1andAIFM2.vm-u 1450 to 1751 1 to 302       302/302
(100 %)
0 diff
(100 %id)
Z38137 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 1471 to 1746 277 to 1       277/277
(100 %)
1 diff
(99.7 %id)
F02950 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 1472 to 1746 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AA918067 2 pooled tumors (clear cell type), Kidney SAR1AandTYSND1andAIFM2.vm-u 1507 to 1746 251 to 12   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 240/240
(100 %)
0 diff
(100 %id)
BG389419 embryonal carcinoma, cell line, testis SAR1AandTYSND1andAIFM2.vm-u 1523 to 1758 1 to 234   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 234/234
(100 %)
2 diff
(99.2 %id)
AI053515 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1754 240 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 221/238
(92 %)
0 diff
(100 %id)
AI054263 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 234 to 17       218/251
(86 %)
0 diff
(100 %id)
AI054315 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 234 to 17       218/251
(86 %)
0 diff
(100 %id)
AI053478 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1746 232 to 20   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 213/230
(92 %)
1 diff
(99.6 %id)
AI252244 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1740 20 to 226   AAA Submitted on the opposite strand 207/226
(91 %)
6 diff
(97.4 %id)
AI251199 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/260
(83 %)
3 diff
(98.9 %id)
AI250535 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/261
(83 %)
2 diff
(99.3 %id)
AI250117 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/255
(85 %)
4 diff
(98.5 %id)
AI246979 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/260
(83 %)
2 diff
(99.3 %id)
AI312247 bone marrow, stem cell 34+/38+ SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 19 to 236     Submitted on the opposite strand 218/270
(80 %)
2 diff
(99.3 %id)
AI340507 bone marrow, stem cell 34+/38+ SAR1AandTYSND1andAIFM2.vm-u 1534 to 1744 20 to 230   AAA Submitted on the opposite strand 211/230
(91 %)
9 diff
(96.1 %id)
AI307460 bone marrow, stem cell 34+/38+ SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/266
(81 %)
4 diff
(98.5 %id)
AI583880 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia SAR1AandTYSND1andAIFM2.vm-u 1534 to 1750 9 to 225     Submitted on the opposite strand 217/262
(82 %)
1 diff
(99.7 %id)
AI583798 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia SAR1AandTYSND1andAIFM2.vm-u 1534 to 1753 10 to 229     Submitted on the opposite strand 220/269
(81 %)
1 diff
(99.7 %id)
AI591288 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/256
(85 %)
4 diff
(98.5 %id)
AI610052 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/256
(85 %)
4 diff
(98.5 %id)
BE138459 ovary, papillary serous carcinoma SAR1AandTYSND1andAIFM2.vm-u 1534 to 1738 41 to 245     Submitted on the opposite strand 205/246
(83 %)
1 diff
(99.6 %id)
AW301768 invasive adenocarcinoma, lung SAR1AandTYSND1andAIFM2.vm-u 1534 to 1683 19 to 168     Submitted on the opposite strand 150/168
(89 %)
6 diff
(96.5 %id)
AW274199 invasive adenocarcinoma, lung SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/263
(82 %)
4 diff
(98.5 %id)
AW301356 invasive adenocarcinoma, lung SAR1AandTYSND1andAIFM2.vm-u 1534 to 1742 38 to 246   AAA Submitted on the opposite strand 209/246
(84 %)
6 diff
(97.6 %id)
AW301389 invasive adenocarcinoma, lung SAR1AandTYSND1andAIFM2.vm-u 1534 to 1751 9 to 226     Submitted on the opposite strand 218/264
(82 %)
2 diff
(99.3 %id)
BE043158 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1744 38 to 248   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 211/250
(84 %)
1 diff
(99.6 %id)
BE043167 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1744 38 to 248   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 211/250
(84 %)
1 diff
(99.6 %id)
BE043848 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1744 38 to 248   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 211/250
(84 %)
1 diff
(99.6 %id)
BE041161 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1534 to 1743 38 to 247   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 210/249
(84 %)
1 diff
(99.6 %id)
BE041891 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1535 to 1751 1 to 217       217/224
(96 %)
4 diff
(98.3 %id)
BE041881 borderline ovarian carcinoma, ovary SAR1AandTYSND1andAIFM2.vm-u 1537 to 1746 1 to 210   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 210/210
(100 %)
2 diff
(99.1 %id)
BF718266 epidermis, skin SAR1AandTYSND1andAIFM2.vm-u 1544 to 1745 203 to 2       202/203
(99 %)
0 diff
(100 %id)
AA860182   SAR1AandTYSND1andAIFM2.vm-u 1577 to 1750 174 to 1       174/174
(100 %)
0 diff
(100 %id)
EC498703 Prostate SAR1AandTYSND1andAIFM2.vm-u 1653 to 1756 104 to 1       104/108
(96 %)
0 diff
(100 %id)
BM742607 Ascites, stomach SAR1AandTYSND1andAIFM2.vm-u 1709 to 2287 1 to 578   tiling clone,   578/578
(100 %)
1 diff
(99.9 %id)
BM770832 Ascites, stomach SAR1AandTYSND1andAIFM2.vm-u 1709 to 2205 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
AA824628 germinal center B cell SAR1AandTYSND1andAIFM2.vm-u 1884 to 2313 1 to 430       430/430
(100 %)
4 diff
(99.1 %id)
AA593528 gastric tumor, stomach SAR1AandTYSND1andAIFM2.vm-u 1999 to 2431 433 to 1   tiling clone,   433/433
(100 %)
1 diff
(99.8 %id)
BM310026 insulinoma, Pancreas SAR1AandTYSND1andAIFM2.vm-u 2209 to 2688 1 to 480       480/480
(100 %)
6 diff
(98.8 %id)
CA442516 Fibrosarcoma SAR1AandTYSND1andAIFM2.vm-u 2340 to 2976 653 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 637/637
(100 %)
1 diff
(99.9 %id)
CB117379 Liver SAR1AandTYSND1andAIFM2.vm-u 2396 to 2783 1 to 388       388/388
(100 %)
3 diff
(99.3 %id)
AA470128   SAR1AandTYSND1andAIFM2.vm-u 2456 to 2976 531 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 521/521
(100 %)
3 diff
(99.5 %id)
AA470130   SAR1AandTYSND1andAIFM2.vm-u 2489 to 2976 496 to 11   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 486/486
(100 %)
3 diff
(99.4 %id)
BF874817 lung_tumor SAR1AandTYSND1andAIFM2.vm-u 2490 to 2788 319 to 21     Submitted on the opposite strand 299/319
(93 %)
0 diff
(100 %id)
AA854826 parathyroid gland, parathyroid tumor SAR1AandTYSND1andAIFM2.vm-u 2512 to 2935 423 to 1       423/423
(100 %)
6 diff
(98.6 %id)
BF475290 carcinoid, lung SAR1AandTYSND1andAIFM2.vm-u 2588 to 2978 392 to 2       391/392
(99 %)
0 diff
(100 %id)
AA429299 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus SAR1AandTYSND1andAIFM2.vm-u 2606 to 2971 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
AW204587   SAR1AandTYSND1andAIFM2.vm-u 2609 to 2980 389 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 372/372
(100 %)
1 diff
(99.8 %id)
AW206205   SAR1AandTYSND1andAIFM2.vm-u 2678 to 2980 320 to 18   AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 303/303
(100 %)
1 diff
(99.7 %id)
F02516 brain, total brain SAR1AandTYSND1andAIFM2.vm-u 2696 to 2976 280 to 1       280/280
(100 %)
1 diff
(99.7 %id)
DA374946 thalamus SAR1AandTYSND1andAIFM2.vn 1 to 549 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA383565 thalamus SAR1AandTYSND1andAIFM2.vn 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
CN281361 embryonic stem cells, cell lines H1, H7, andH9 SAR1AandTYSND1andAIFM2.vn 255 to 945 1 to 691   tiling clone,   691/691
(100 %)
2 diff
(99.8 %id)
DA173686 amygdala SAR1AandTYSND1andAIFM2.vn 277 to 833 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AK097697 testis SAR1AandTYSND1andAIFM2.vn 752 to 2860 1 to 2109   tiling clone, available from FLJ,   2109/2109
(100 %)
2 diff
(100.0 %id)
DB046636 testis SAR1AandTYSND1andAIFM2.vn 753 to 1308 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AI125876   SAR1AandTYSND1andAIFM2.vn 953 to 1358 431 to 26   AAA   406/406
(100 %)
2 diff
(99.6 %id)
BG946229 bladder_tumor SAR1AandTYSND1andAIFM2.vn 1113 to 1509 402 to 4       399/421
(94 %)
0 diff
(100 %id)
BG282659 adenocarcinoma, cell line, Prostate SAR1AandTYSND1andAIFM2.vn 1394 to 2105 1 to 702       702/925
(75 %)
18 diff
(98.1 %id)
DB338248 testis SAR1AandTYSND1andAIFM2.vn 2326 to 2860 535 to 1       535/535
(100 %)
0 diff
(100 %id)
AK074968   SAR1AandTYSND1andAIFM2.vo 1 to 2621 2 to 2619   tiling clone, available from FLJ,   2619/2619
(100 %)
5 diff
(99.9 %id)
DA736445   SAR1AandTYSND1andAIFM2.vo 1 to 757 2 to 757 A91Q E92K A93P P94R R95G ... capped   756/756
(100 %)
4 diff
(99.5 %id)
CB142431 Liver SAR1AandTYSND1andAIFM2.vo 9 to 261 1 to 253       253/253
(100 %)
4 diff
(98.5 %id)
DB368926   SAR1AandTYSND1andAIFM2.vo 2103 to 2621 517 to 1       517/520
(99 %)
8 diff
(98.5 %id)
BI598444 brain, hypothalamus SAR1AandTYSND1andAIFM2.vp 1 to 596 7 to 602   available from MGC,   602/602
(100 %)
5 diff
(99.2 %id)
BC047424 Brain, hypothalamus SAR1AandTYSND1andAIFM2.vp 1 to 2240 2 to 2241 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 2241/2241
(100 %)
3 diff
(99.9 %id)
TI_45212334   SAR1AandTYSND1andAIFM2.vp 1 to 596 89 to 684       597/684
(87 %)
6 diff
(99.2 %id)
DB449952 testis SAR1AandTYSND1andAIFM2.vp 45 to 496 1 to 453       453/453
(100 %)
6 diff
(98.7 %id)
CD172154 White Matter SAR1AandTYSND1andAIFM2.vq 1 to 760 1 to 765   tiling clone,   765/797
(95 %)
6 diff
(99.3 %id)
DA194813 amygdala SAR1AandTYSND1andAIFM2.vq 430 to 971 2 to 543 exact tiling clone, capped   542/548
(98 %)
2 diff
(99.7 %id)
DB442510 testis SAR1AandTYSND1andAIFM2.vr 1 to 423 1 to 425   tiling clone,   425/428
(99 %)
3 diff
(99.3 %id)
BG426432 Kidney SAR1AandTYSND1andAIFM2.vr 2 to 926 1 to 910 L45* tiling clone,   906/951
(95 %)
38 diff
(96.1 %id)
DB444524 testis SAR1AandTYSND1andAIFM2.vr 26 to 456 1 to 430       432/430
(100 %)
9 diff
(98.0 %id)
DA434127 tongue, tumor tissue SAR1AandTYSND1andAIFM2.vr 31 to 505 2 to 476   tiling clone, capped   475/475
(100 %)
0 diff
(100 %id)
BF326541 breast_normal SAR1AandTYSND1andAIFM2.vs-u 1 to 215 11 to 227   tiling clone,   227/231
(98 %)
7 diff
(97.0 %id)
EL593994 epidermis, skin SAR1AandTYSND1andAIFM2.vs-u 124 to 863 26 to 761 exact tiling clone,   736/764
(96 %)
17 diff
(97.8 %id)
AL040484 testis SAR1AandTYSND1andAIFM2.vs-u 305 to 822 1 to 517   tiling clone,   517/517
(100 %)
3 diff
(99.5 %id)
AA909726 pooled SAR1AandTYSND1andAIFM2.vt-u 1 to 580 5 to 585   tiling clone, Submitted on the opposite strand 585/585
(100 %)
3 diff
(99.5 %id)
AW978838   SAR1AandTYSND1andAIFM2.vt-u 1 to 633 4 to 636 A3T L14V G16* tiling clone,   636/636
(100 %)
12 diff
(98.2 %id)
AA848036 germinal center B cell SAR1AandTYSND1andAIFM2.vt-u 52 to 411 1 to 360       360/360
(100 %)
3 diff
(99.2 %id)
AW938548 denis_drash SAR1AandTYSND1andAIFM2.vt-u 69 to 397 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
BE143944 head_neck SAR1AandTYSND1andAIFM2.vt-u 155 to 309 155 to 2     Submitted on the opposite strand 154/184
(83 %)
0 diff
(100 %id)
BE143998 head_neck SAR1AandTYSND1andAIFM2.vt-u 155 to 309 155 to 2     Submitted on the opposite strand 154/184
(83 %)
0 diff
(100 %id)
DB163215 thymus SAR1AandTYSND1andAIFM2.vu 1 to 590 5 to 594 exact tiling clone, capped   593/593
(100 %)
0 diff
(100 %id)
BQ299765 bladder_tumor SAR1AandTYSND1andAIFM2.vu 57 to 585 37 to 565 S2F F5L E6K W7S I8F ...     532/565
(94 %)
9 diff
(98.5 %id)
DA334145 hippocampus SAR1AandTYSND1andAIFM2.vv 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DB106745 thymus SAR1AandTYSND1andAIFM2.vw-u 1 to 572 2 to 573 Y2C S18G tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DB212649 trachea SAR1AandTYSND1andAIFM2.vx-u 1 to 564 2 to 565 exact tiling clone, capped   564/564
(100 %)
1 diff
(99.9 %id)
DA681365 ovary SAR1AandTYSND1andAIFM2.vy-u 1 to 553 2 to 555 exact tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
BU659848 blood SAR1AandTYSND1andAIFM2.vz 1 to 468 12 to 479 exact tiling clone,   468/479
(97 %)
6 diff
(98.8 %id)
DB225554 trachea SAR1AandTYSND1andAIFM2.wa 1 to 436 2 to 438 exact tiling clone, capped   437/437
(100 %)
2 diff
(99.6 %id)
D78751 placenta SAR1AandTYSND1andAIFM2.wb-u 1 to 375 1 to 374 exact tiling clone,   374/374
(100 %)
6 diff
(98.4 %id)
BG941807 blood SAR1AandTYSND1andAIFM2.wc 1 to 290 1 to 290 exact tiling clone,   290/290
(100 %)
2 diff
(99.4 %id)
CR737058 pooled SAR1AandTYSND1andAIFM2.wd-u 1 to 227 1 to 227 R45G E47X C48X N49X tiling clone,   227/227
(100 %)
1 diff
(99.6 %id)
AA371527   Gene SAR1AandTYSND1andAIFM2, variant not shown              
BC023601 Lung, large cell carcinoma Gene SAR1AandTYSND1andAIFM2, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BF735786 amnion_normal Gene SAR1AandTYSND1andAIFM2, variant not shown              
BI060687 uterus_tumor Gene SAR1AandTYSND1andAIFM2, variant not shown              
BX089753 eye, retina Gene SAR1AandTYSND1andAIFM2, variant not shown              
CN307422 embryonic stem cells, DMSO-treated H9 cellline Gene SAR1AandTYSND1andAIFM2, variant not shown       AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base)    
CN307423 embryonic stem cells, DMSO-treated H9 cellline Gene SAR1AandTYSND1andAIFM2, variant not shown              
DB523811 testis Gene SAR1AandTYSND1andAIFM2, variant not shown         Submitted on the opposite strand    
DB458313 testis Gene SAR1AandTYSND1andAIFM2, variant not shown         Submitted on the opposite strand    
AI612767 serous papillary carcinoma, high grade, 2pooled tumors, uterus Gene SAR1AandTYSND1andAIFM2, variant not shown              
AI916367 Kidney Gene SAR1AandTYSND1andAIFM2, variant not shown              
BQ707053 Spleen Gene SAR1AandTYSND1andAIFM2, variant not shown         This clone was ignored    
169 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh-u, .vi, .vj, .vk, .vl-u, .vm-u, .vn, .vo, .vp, .vq, .vr, .vs-u, .vt-u, .vu, .vv, .vw-u, .vx-u, .vy-u, .vz, .wa, .wb-u, .wc, .wd-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI